These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
REGISTRATION STATEMENT PURSUANT TO SECTIONS 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
The
|
|
|
(Jurisdiction of Incorporation or Organization)
|
|
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on which Registered
|
||
|
|
|
|
|
|
þ
|
Accelerated filer
o
|
Non-accelerated filer
o
|
||
|
Emerging growth company
|
|
|
Page
|
||
|
BOARD OF DIRECTORS
|
|
Chairman
John Elkann
|
|
Vice Chairman
Robert Peugeot
(3)
|
|
Directors
Henri de Castries
(1),(2),(3)
Fiona Clare Cicconi
(1),(3)
Nicolas Dufourcq
(1)
Ann Frances Godbehere
(2)
Wan Ling Martello
(2),(3)
Claudia Parzani
(1),(2)
Benoît Ribadeau-Dumas
(1),(3)
Jacques de Saint-Exupéry
|
|
INDEPENDENT AUDITOR AND REGISTERED PUBLIC ACCOUNTING FIRM
Deloitte Accountants B.V. (independent auditor of the Company for the purposes of our annual reports file with the
Autoriteit Financiële Markten (“AFM”))
(4)
Deloitte & Associés (independent registered public accounting firm for our Consolidated Financial Statements included in
our reports on Form 20-F)
(4)
|
|
Stellantis Shareholders
|
Number of Issued
Common Shares
(1)
|
Percentage of
Issued Common
Shares
|
||
|
Exor
(2)
|
449,410,092
|
15.52
|
||
|
EPF
(3
)
|
224,228,121
|
7.74
|
||
|
BPI
(4)
|
192,703,907
|
6.65
|
||
|
BlackRock Inc.
(5)
|
96,885,231
|
3.34
|
||
|
Capital Research and Management Company
(6)
|
—
|
—
|
|
At December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
North America
|
75,554
|
81,341
|
88,835
|
||
|
Enlarged Europe
|
126,242
|
135,211
|
142,681
|
||
|
Middle East & Africa
|
7,874
|
6,101
|
5,311
|
||
|
South America
|
32,612
|
28,928
|
28,968
|
||
|
China and India & Asia Pacific
|
5,961
|
6,694
|
6,572
|
||
|
Total
|
248,243
|
258,275
|
272,367
|
||
|
Years ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
(millions of units)
|
||||||
|
North America
|
1.5
|
1.8
|
1.8
|
|||
|
Enlarged Europe
|
2.6
|
2.7
|
2.6
|
|||
|
Middle East & Africa
|
0.5
|
0.6
|
0.4
|
|||
|
South America
|
0.9
|
0.9
|
0.8
|
|||
|
China and India & Asia Pacific
|
0.1
|
0.2
|
0.2
|
|||
|
Total Regions
|
5.7
|
6.1
|
5.8
|
|||
|
Maserati
|
0.01
|
0.03
|
0.02
|
|||
|
Total Worldwide
|
5.7
|
6.2
|
5.8
|
|||
|
Years ended December 31,
|
||||||||||||
|
2024
(1)
|
2023
(1)
|
2022
(1)
|
||||||||||
|
North America
|
Sales
|
Market Share
|
Sales
|
Market Share
|
Sales
|
Market Share
|
||||||
|
Thousands of units (except percentages)
|
||||||||||||
|
U.S.
|
1,304
|
8.0
%
|
1,527
|
9.6
%
|
1,547
|
10.9
%
|
||||||
|
Canada
|
130
|
7.2
%
|
158
|
9.5
%
|
169
|
11.4
%
|
||||||
|
Mexico
|
94
|
6.0
%
|
97
|
6.8
%
|
74
|
6.6
%
|
||||||
|
Total
|
1,527
|
7.8
%
|
1,782
|
9.4
%
|
1,791
|
10.7
%
|
||||||
|
Years ended December 31,
|
||||||
|
U.S.
|
2024
|
2023
|
2022
|
|||
|
Automaker
|
Percentage of industry
|
|||||
|
GM
|
16.6
%
|
16.3
%
|
16.1
%
|
|||
|
Toyota
|
14.3
%
|
14.2
%
|
14.9
%
|
|||
|
Ford
|
12.8
%
|
12.5
%
|
13.2
%
|
|||
|
Hyundai/Kia
|
10.5
%
|
10.4
%
|
10.4
%
|
|||
|
Honda
|
8.7
%
|
8.2
%
|
7.0
%
|
|||
|
Stellantis
(1)
|
8.0
%
|
9.6
%
|
10.9
%
|
|||
|
Nissan
|
5.7
%
|
5.7
%
|
5.2
%
|
|||
|
Other
|
23.4
%
|
23.1
%
|
22.4
%
|
|||
|
Total
|
100
%
|
100
%
|
100
%
|
|||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Enlarged Europe
(1)
|
Sales
|
Market Share
|
Sales
|
Market Share
|
Sales
|
Market Share
|
||||||
|
Thousands of units (except percentages)
|
||||||||||||
|
France
|
599
|
28.5
%
|
634
|
29.4
%
|
620
|
33.1
%
|
||||||
|
Italy
|
531
|
30.2
%
|
591
|
33.5
%
|
535
|
36.3
%
|
||||||
|
Germany
|
416
|
13.4
%
|
389
|
12.5
%
|
371
|
12.9
%
|
||||||
|
UK
|
299
|
12.9
%
|
313
|
13.9
%
|
268
|
14.1
%
|
||||||
|
Spain
|
208
|
17.6
%
|
221
|
20.2
%
|
214
|
22.9
%
|
||||||
|
Other
|
502
|
11.1
%
|
546
|
12.5
%
|
545
|
14.1
%
|
||||||
|
Europe
(2)
|
2,555
|
17.0
%
|
2,695
|
18.3
%
|
2,553
|
19.7
%
|
||||||
|
Other Europe
(3)
|
21
|
2.8
%
|
18
|
2.4
%
|
16
|
3.0
%
|
||||||
|
Total
|
2,577
|
16.4
%
|
2,713
|
17.5
%
|
2,569
|
19.1
%
|
||||||
|
Years ended December 31,
|
||||||
|
Europe 30
(1)
|
2024
|
2023
|
2022
|
|||
|
Automaker
|
Percentage of industry
|
|||||
|
Volkswagen
|
24.3
%
|
24.0
%
|
23.0
%
|
|||
|
Stellantis
(2)
|
17.0
%
|
18.3
%
|
19.7
%
|
|||
|
Renault
|
10.7
%
|
10.5
%
|
10.1
%
|
|||
|
Toyota
|
7.4
%
|
6.7
%
|
6.8
%
|
|||
|
Hyundai/Kia
|
7.1
%
|
7.5
%
|
8.2
%
|
|||
|
Mercedes-Benz
|
6.2
%
|
6.2
%
|
6.5
%
|
|||
|
BMW
|
6.2
%
|
6.2
%
|
6.3
%
|
|||
|
Ford
|
5.5
%
|
5.9
%
|
6.5
%
|
|||
|
Other
|
15.6
%
|
14.7
%
|
12.8
%
|
|||
|
Total
|
100
%
|
100
%
|
100
%
|
|||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Middle East & Africa
|
Sales
|
Market Share
|
Sales
|
Market Share
|
Sales
|
Market Share
|
||||||
|
Thousands of units (except percentages)
|
||||||||||||
|
Turkey
|
343
|
27.7
%
|
419
|
34.0
%
|
250
|
31.9
%
|
||||||
|
Algeria
|
67
|
65.2
%
|
56
|
86.5
%
|
14
|
53.5
%
|
||||||
|
Morocco
|
35
|
19.9
%
|
33
|
20.7
%
|
34
|
20.8
%
|
||||||
|
Gulf
(1)
|
30
|
2.0
%
|
33
|
2.4
%
|
26
|
2.3
%
|
||||||
|
Overseas France
(2)
|
19
|
28.5
%
|
21
|
28.8
%
|
24
|
33.8
%
|
||||||
|
Israel Zone
(3)
|
14
|
5.2
%
|
21
|
7.4
%
|
22
|
8.0
%
|
||||||
|
Egypt
|
6
|
7.1
%
|
8
|
10.8
%
|
17
|
16.3
%
|
||||||
|
Other
(4)
|
24
|
2.6
%
|
23
|
2.6
%
|
27
|
3.0
%
|
||||||
|
Total
|
538
|
12.4
%
|
614
|
14.8
%
|
415
|
11.9
%
|
||||||
|
Years ended December 31,
|
||||||
|
G6
(1)
Middle East & Africa
|
2024
|
2023
|
2022
|
|||
|
Automaker
|
Percentage of industry
|
|||||
|
Toyota
|
17.5
%
|
18.0
%
|
20.3
%
|
|||
|
Stellantis
(2)
|
13.5
%
|
16.8
%
|
14.8
%
|
|||
|
Hyundai/Kia
|
13.1
%
|
13.3
%
|
13.9
%
|
|||
|
Volkswagen
|
8.2
%
|
7.7
%
|
6.8
%
|
|||
|
Renault
|
8.2
%
|
8.6
%
|
9.3
%
|
|||
|
Ford
|
5.5
%
|
5.2
%
|
4.7
%
|
|||
|
Nissan
|
5.2
%
|
4.9
%
|
5.0
%
|
|||
|
Mercedes-Benz
|
1.6
%
|
1.4
%
|
1.4
%
|
|||
|
BMW
|
1.2
%
|
1.1
%
|
1.1
%
|
|||
|
Other
|
26.0
%
|
22.9
%
|
22.7
%
|
|||
|
Total
|
100
%
|
100
%
|
100
%
|
|||
|
Years ended December 31,
|
||||||||||||
|
2024
(1)
|
2023
(1)
|
2022
(1)
|
||||||||||
|
South America
|
Sales
|
Market Share
|
Sales
|
Market Share
|
Sales
|
Market Share
|
||||||
|
Thousands of units (except percentages)
|
||||||||||||
|
Brazil
|
734
|
29.4
%
|
687
|
31.4
%
|
647
|
32.9
%
|
||||||
|
Argentina
|
116
|
29.7
%
|
120
|
28.2
%
|
117
|
30.7
%
|
||||||
|
Other South America
|
66
|
5.9
%
|
72
|
6.4
%
|
80
|
6.2
%
|
||||||
|
Total
|
916
|
22.9
%
|
879
|
23.5
%
|
844
|
23.2
%
|
||||||
|
Brazil
|
Years ended December 31,
|
|||||
|
2024
(1)
|
2023
(1)
|
2022
(1)
|
||||
|
Automaker
|
Percentage of industry
|
|||||
|
Stellantis
(2)
|
29.4
%
|
31.4
%
|
32.9
%
|
|||
|
Volkswagen
|
16.6
%
|
16.4
%
|
14.3
%
|
|||
|
GM
|
12.6
%
|
15.0
%
|
14.8
%
|
|||
|
Ford
|
1.9
%
|
1.3
%
|
1.1
%
|
|||
|
Other
|
39.4
%
|
35.9
%
|
37.0
%
|
|||
|
Total
|
100
%
|
100
%
|
100
%
|
|||
|
Years ended December 31,
|
||||||||||||
|
2024
(1)(5)
|
2023
(1)(5)
|
2022
(1)(5)
|
||||||||||
|
China and India &
Asia Pacific
|
Sales
|
Market Share
|
Sales
|
Market Share
|
Sales
|
Market Share
|
||||||
|
Thousands of units (except percentages)
|
||||||||||||
|
China
(2)*
|
48
|
0.2
%
|
69
|
0.3
%
|
94
|
0.4
%
|
||||||
|
Japan
|
25
|
0.7
%
|
33
|
0.8
%
|
34
|
1.0
%
|
||||||
|
India
(3)
|
12
|
0.3
%
|
17
|
0.4
%
|
20
|
0.5
%
|
||||||
|
Australia
|
11
|
0.9
%
|
18
|
1.5
%
|
18
|
1.7
%
|
||||||
|
Asean & General
Distributors (“AGD”)
(4)
|
11
|
0.3
%
|
12
|
0.3
%
|
20
|
0.6
%
|
||||||
|
South Korea
|
4
|
0.2
%
|
7
|
0.4
%
|
9
|
0.6
%
|
||||||
|
New Zealand
|
1
|
1.2
%
|
3
|
1.8
%
|
3
|
2.1
%
|
||||||
|
China and India & Asia
Pacific major Markets
|
112
|
0.3
%
|
157
|
0.4
%
|
198
|
0.6
%
|
||||||
|
Other China and India
& Asia Pacific
|
1
|
—
%
|
2
|
—
%
|
1
|
—
%
|
||||||
|
Total
|
113
|
0.3
%
|
159
|
0.4
%
|
199
|
0.5
%
|
||||||
|
2024
Sales
|
As a
percentage of
2024
sales
|
2023
Sales
|
As a
percentage of
2023
sales
|
2022
Sales
|
As a
percentage of
2022
sales
|
|||||||
|
U.S./Mexico
|
4,807
|
32.6
%
|
7,907
|
29.6
%
|
6,945
|
29.7
%
|
||||||
|
Europe top 4
(1)
|
3,733
|
25.4
%
|
6,035
|
22.6
%
|
5,442
|
23.3
%
|
||||||
|
China
|
1,209
|
8.2
%
|
4,367
|
16.4
%
|
4,680
|
20.0
%
|
||||||
|
Japan
|
1,102
|
7.5
%
|
1,729
|
6.5
%
|
1,238
|
5.3
%
|
||||||
|
Other countries
|
3,874
|
26.3
%
|
6,651
|
24.9
%
|
5,099
|
21.8
%
|
||||||
|
Total
|
14,725
|
100.0
%
|
26,689
|
100.0
%
|
23,404
|
100.0
%
|
|
Years ended December 31,
|
||||
|
(thousands of units)
|
2024
|
2023
|
||
|
North America
|
1,432
|
1,903
|
||
|
Enlarged Europe
|
2,576
|
2,814
|
||
|
Middle East & Africa
|
423
|
443
|
||
|
South America
|
912
|
879
|
||
|
China and India & Asia Pacific
|
61
|
102
|
||
|
Maserati
|
11
|
27
|
||
|
Total Consolidated shipments
|
5,415
|
6,168
|
||
|
Joint venture shipments
|
111
|
225
|
||
|
Total Combined shipments
|
5,526
|
6,393
|
||
|
Years ended December 31,
|
||||
|
(€ million)
|
2024
|
2023
|
||
|
Net revenues
|
€
156,878
|
€
189,544
|
||
|
Cost of revenues
|
136,360
|
151,400
|
||
|
Selling, general and other costs
|
9,299
|
9,541
|
||
|
Research and development costs
|
5,784
|
5,619
|
||
|
Gains/(losses) on disposal of investments
|
(98)
|
20
|
||
|
Restructuring costs
|
1,617
|
1,119
|
||
|
Share of the profit/(loss) of equity method investees
|
(33)
|
491
|
||
|
Operating income/(loss)
|
3,687
|
22,376
|
||
|
Net financial expenses/(income)
|
(345)
|
(42)
|
||
|
Profit/(loss) before taxes
|
4,032
|
22,418
|
||
|
Tax expenses/(benefit)
|
(1,488)
|
3,793
|
||
|
Net profit/(loss)
|
€
5,520
|
€
18,625
|
||
|
Net profit/(loss) attributable to:
|
||||
|
Owners of the parent
|
€
5,473
|
€
18,596
|
||
|
Non-controlling interests
|
€
47
|
€
29
|
||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Net revenues
|
€
156,878
|
€
189,544
|
(17.2)
%
|
|||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Cost of revenues
|
€
136,360
|
€
151,400
|
(9.9)
%
|
|||
|
Cost of revenues as % of Net revenues
|
86.9
%
|
79.9
%
|
||||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Selling, general and other costs
|
€
9,299
|
€
9,541
|
(2.5)
%
|
|||
|
Selling, general and other costs as % of Net revenues
|
5.9
%
|
5.0
%
|
||||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Research and development expenditures expensed
|
€
2,932
|
€
3,300
|
(11.2)
%
|
|||
|
Amortization of capitalized development expenditures
|
2,149
|
2,193
|
(2.0)
%
|
|||
|
Impairment and write-off of capitalized development
expenditures
|
703
|
126
|
457.9
%
|
|||
|
Total Research and development costs
|
€
5,784
|
€
5,619
|
2.9
%
|
|||
|
Years ended December 31,
|
||||
|
(€ million)
|
2024
|
2023
|
||
|
Research and development expenditures expensed as % of Net revenues
|
1.9
%
|
1.7
%
|
||
|
Amortization of capitalized development expenditures as % of Net revenues
|
1.4
%
|
1.2
%
|
||
|
Impairment and write-off of capitalized development expenditures as % of Net revenues
|
0.4
%
|
0.1
%
|
||
|
Total Research and development costs as % of Net revenues
|
3.7
%
|
3.0
%
|
||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Capitalized development expenditures excl.borrowing costs
(1)
|
€
3,922
|
€
4,184
|
(6.3)
%
|
|||
|
Research and development expenditures expensed
|
2,932
|
3,300
|
(11.2)
%
|
|||
|
Total Research and development expenditures
|
€
6,854
|
€
7,484
|
(8.4)
%
|
|||
|
Capitalized development expenditures as % of Total Research
and development expenditures
|
57.2
%
|
55.9
%
|
||||
|
Total Research and development expenditures as % of Net
revenues
|
4.4
%
|
3.9
%
|
||||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Restructuring costs
|
€
1,617
|
€
1,119
|
44.5
%
|
|||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Share of the profit/(loss) of equity method investees
|
€
(33)
|
€
491
|
(106.7)
%
|
|||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Net financial expenses/(income)
|
€
(345)
|
€
(42)
|
721.4
%
|
|||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Tax expense/(benefit)
|
€
(1,488)
|
€
3,793
|
(139.2)
%
|
|||
|
Effective tax rate
|
(36.9)
%
|
16.9
%
|
-5,380 bps
|
|||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Net profit/(loss)
|
€
5,520
|
€
18,625
|
(70.4)
%
|
|||
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ million)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Adjusted operating income
|
€
8,648
|
€
24,343
|
(64.5)
%
|
|||
|
Adjusted operating income margin (%)
|
5.5
%
|
12.8
%
|
-730 bps
|
|||
|
Year ended December 31,
|
||
|
(€ million)
|
2024
|
|
|
Net profit/(loss)
|
€
5,520
|
|
|
Tax expense/(benefit)
|
(1,488)
|
|
|
Net financial expenses/(income)
|
(345)
|
|
|
Operating income/(loss)
|
3,687
|
|
|
Adjustments:
|
||
|
Restructuring and other costs, net of reversals
|
1,617
|
|
|
Impairment expense and supplier obligations
|
1,807
|
|
|
Takata recall campaign
|
768
|
|
|
Lifetime Onerous Contracts
|
637
|
|
|
Other
|
132
|
|
|
Total adjustments
|
4,961
|
|
|
Adjusted operating income
|
€
8,648
|
|
Year ended December 31,
|
||
|
(€ million)
|
2023
|
|
|
Net profit/(loss)
|
€
18,625
|
|
|
Tax expense/(benefit)
|
3,793
|
|
|
Net financial expenses/(income)
|
(42)
|
|
|
Operating income/(loss)
|
22,376
|
|
|
Adjustments:
|
||
|
Restructuring and other costs, net of reversals
|
1,161
|
|
|
Collective bargaining agreements costs
|
428
|
|
|
Argentina currency devaluation
|
302
|
|
|
Impairment expense and supplier obligations
|
201
|
|
|
Reorganization of financial services
|
76
|
|
|
Takata recall campaign
|
(10)
|
|
|
Patents litigation
|
(61)
|
|
|
Gains on disposal of equity investments and other assets
|
(201)
|
|
|
Other
|
71
|
|
|
Total adjustments
|
1,967
|
|
|
Adjusted operating income
|
€
24,343
|
|
Years ended December 31,
|
Increase/(Decrease)
|
|||||
|
(€ per share)
|
2024
|
2023
|
2024 vs. 2023
|
|||
|
Diluted EPS
|
€
1.84
|
€
5.94
|
(69.0)
%
|
|||
|
Adjusted diluted EPS
|
€
2.48
|
€
6.42
|
(61.4)
%
|
|||
|
Years ended December 31,
|
||||
|
(€ million except otherwise noted)
|
2024
|
2023
|
||
|
Net profit attributable to owners of the parent
|
5,473
|
18,596
|
||
|
Weighted average number of shares outstanding (000)
|
2,949,652
|
3,107,725
|
||
|
Number of shares deployable for share-based compensation (000)
|
26,168
|
24,733
|
||
|
Weighted average number of shares outstanding for diluted earnings per share (000)
|
2,975,820
|
3,132,458
|
||
|
Diluted earnings per share (A) (€/share)
|
1.84
|
5.94
|
||
|
Adjustments, per above
|
4,961
|
1,967
|
||
|
Tax impact on adjustments
(1)
|
(799)
|
(452)
|
||
|
Unusual items related to income taxes
(2)
|
(2,266)
|
—
|
||
|
Total adjustments, net of taxes
|
1,896
|
1,515
|
||
|
Impact of adjustments above, net of taxes, on Diluted earnings per share from continuing
operations (B) (€/share)
|
0.64
|
0.48
|
||
|
Adjusted Diluted earnings per share (€/share) (A+B)
|
2.48
|
6.42
|
||
|
(€ million, except shipments
which are in thousands of units)
|
Net revenues
|
Adjusted operating income
|
Consolidated Shipments
|
|||||||||
|
Years ended December 31,
|
||||||||||||
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
|||||||
|
North America
|
€
63,450
|
€
86,500
|
€
2,660
|
€
13,298
|
1,432
|
1,903
|
||||||
|
Enlarged Europe
|
59,010
|
66,598
|
2,419
|
6,519
|
2,576
|
2,814
|
||||||
|
Middle East & Africa
|
10,097
|
10,560
|
1,901
|
2,503
|
423
|
443
|
||||||
|
South America
|
15,863
|
16,058
|
2,272
|
2,369
|
912
|
879
|
||||||
|
China and India & Asia Pacific
|
1,993
|
3,528
|
(58)
|
502
|
61
|
102
|
||||||
|
Maserati
|
1,040
|
2,335
|
(260)
|
141
|
11
|
27
|
||||||
|
Total Segments
|
151,453
|
185,579
|
8,934
|
25,332
|
5,415
|
6,168
|
||||||
|
Other activities
|
6,151
|
5,211
|
144
|
(322)
|
—
|
—
|
||||||
|
Unallocated items &
eliminations
(1)
|
(726)
|
(1,246)
|
(430)
|
(667)
|
—
|
—
|
||||||
|
Total
|
€
156,878
|
€
189,544
|
€
8,648
|
€
24,343
|
5,415
|
6,168
|
||||||
|
Years ended December 31,
|
Increase/
(Decrease)
|
|||||
|
2024
|
2023
|
2024 vs. 2023
|
||||
|
Consolidated shipments (thousands of units)
|
1,432
|
1,903
|
(24.8)
%
|
|||
|
Net revenues (€ million)
|
€
63,450
|
€
86,500
|
(26.6)
%
|
|||
|
Adjusted operating income (€ million)
|
€
2,660
|
€
13,298
|
(80.0)
%
|
|||
|
Adjusted operating income margin (%)
|
4.2
%
|
15.4
%
|
-1,120 bps
|
|||
|
Years ended December 31,
|
Increase/
(Decrease)
|
|||||
|
2024
|
2023
|
2024 vs. 2023
|
||||
|
Consolidated shipments (thousands of units)
|
2,576
|
2,814
|
(8.5)
%
|
|||
|
Net revenues (€ million)
|
€
59,010
|
€
66,598
|
(11.4)
%
|
|||
|
Adjusted operating income (€ million)
|
€
2,419
|
€
6,519
|
(62.9)
%
|
|||
|
Adjusted operating income margin (%)
|
4.1
%
|
9.8
%
|
-570 bps
|
|||
|
Years ended December 31,
|
Increase/
(Decrease)
|
|||||
|
2024
|
2023
|
2024 vs. 2023
|
||||
|
Combined shipments (thousands of units)
|
534
|
616
|
(13.3)
%
|
|||
|
Consolidated shipments (thousands of units)
|
423
|
443
|
(4.5)
%
|
|||
|
Net revenues (€ million)
|
€
10,097
|
€
10,560
|
(4.4)
%
|
|||
|
Adjusted operating income (€ million)
|
€
1,901
|
€
2,503
|
(24.1)
%
|
|||
|
Adjusted operating income margin (%)
|
18.8
%
|
23.7
%
|
-490 bps
|
|||
|
Years ended December 31,
|
Increase/
(Decrease)
|
|||||
|
2024
|
2023
|
2024 vs. 2023
|
||||
|
Consolidated shipments (thousands of units)
|
912
|
879
|
3.8
%
|
|||
|
Net revenues (€ million)
|
€
15,863
|
€
16,058
|
(1.2)
%
|
|||
|
Adjusted operating income (€ million)
|
€
2,272
|
€
2,369
|
(4.1)
%
|
|||
|
Adjusted operating income margin (%)
|
14.3
%
|
14.8
%
|
-50 bps
|
|||
|
Years ended December 31,
|
Increase/
(Decrease)
|
|||||
|
2024
|
2023
|
2024 vs. 2023
|
||||
|
Combined shipments (thousands of units)
|
61
|
154
|
(60.4)
%
|
|||
|
Consolidated shipments (thousands of units)
|
61
|
102
|
(40.2)
%
|
|||
|
Net revenues (€ million)
|
€
1,993
|
€
3,528
|
(43.5)
%
|
|||
|
Adjusted operating income (€ million)
|
€
(58)
|
€
502
|
(111.6)
%
|
|||
|
Adjusted operating income margin (%)
|
(2.9)
%
|
14.2
%
|
-1,710 bps
|
|||
|
Years ended December 31,
|
Increase/
(Decrease)
|
|||||
|
2024
|
2023
|
2024 vs. 2023
|
||||
|
Consolidated shipments (thousands of units)
|
11.3
|
26.6
|
(57.5)
%
|
|||
|
Net revenues (€ million)
|
€
1,040
|
€
2,335
|
(55.5)
%
|
|||
|
Adjusted operating income (€ million)
|
€
(260)
|
€
141
|
(284.4)
%
|
|||
|
Adjusted operating income margin (%)
|
(25.0)
%
|
6.0
%
|
-3,100 bps
|
|||
|
At December 31,
|
||||
|
(€ million)
|
2024
|
2023
|
||
|
Cash, cash equivalents and financial securities
(1)
|
€
38,568
|
€
49,758
|
||
|
Undrawn committed credit lines
|
12,915
|
12,621
|
||
|
Cash, cash equivalents and financial securities - included with Assets held for sale
|
297
|
231
|
||
|
Total Available liquidity
(2)
|
€
51,780
|
€
62,610
|
||
|
of which: Available liquidity of the Industrial Activities
|
€
49,481
|
€
61,056
|
||
|
Years ended December 31,
|
||||||
|
(€ million)
|
2024
|
2023
|
2022
|
|||
|
Cash flows from (used in) operating activities
|
€
4,008
|
€
22,485
|
€
19,959
|
|||
|
Cash flows from (used in) investing activities
|
(15,982)
|
(15,047)
|
(10,531)
|
|||
|
Cash flows from (used in) financing activities
|
2,061
|
(9,200)
|
(13,167)
|
|||
|
Effect of changes in exchange rates
|
410
|
(836)
|
608
|
|||
|
(Increase)/decrease in cash and cash equivalents included in asset held for sale
|
(66)
|
(166)
|
(65)
|
|||
|
Increase/(decrease) in cash and cash equivalents
|
(9,569)
|
(2,764)
|
(3,196)
|
|||
|
Net cash and cash equivalents at beginning of the period
|
43,669
|
46,433
|
49,629
|
|||
|
NET CASH AND CASH EQUIVALENTS AT END OF PERIOD
|
€
34,100
|
€
43,669
|
€
46,433
|
|||
|
Years ended December 31,
|
||||
|
(€ million)
|
2024
|
2023
|
||
|
Cash flows from/(used in) operating activities
|
€
4,008
|
€
22,485
|
||
|
Less: Financial services, net of inter-segment eliminations
|
(2,736)
|
(753)
|
||
|
Less: Capital expenditures and capitalized research and development expenditures and change
in amounts payable on property, plant and equipment and intangible assets for industrial
activities
|
10,761
|
9,031
|
||
|
Add: Proceeds from disposal of assets and other changes in investing activities
|
303
|
2,152
|
||
|
Less: Net proceeds related to the reorganization of financial services in Europe
(1)
|
—
|
1,532
|
||
|
Less: Contributions of equity to joint ventures and minor acquisitions of consolidated
subsidiaries and equity method and other investments
|
2,376
|
2,767
|
||
|
Add: Defined benefit pension contribution, net of tax
|
45
|
798
|
||
|
Industrial free cash flows
|
(6,045)
|
12,858
|
||
|
At December 31, 2024
|
At December 31, 2023
|
|||||||||||
|
(€ million)
|
Company
|
Industrial
activities
|
Financial
services
|
Company
|
Industrial
activities
|
Financial
services
|
||||||
|
Third parties debt (Principal)
|
(36,609)
|
(23,499)
|
(13,110)
|
(28,792)
|
(22,018)
|
(6,774)
|
||||||
|
Capital market
(1)
|
(20,003)
|
(18,542)
|
(1,461)
|
(18,637)
|
(17,555)
|
(1,082)
|
||||||
|
Bank debt
|
(3,562)
|
(1,902)
|
(1,660)
|
(2,847)
|
(1,990)
|
(857)
|
||||||
|
Other debt
(2)
|
(10,488)
|
(515)
|
(9,973)
|
(5,150)
|
(334)
|
(4,816)
|
||||||
|
Lease liabilities
|
(2,556)
|
(2,540)
|
(16)
|
(2,158)
|
(2,139)
|
(19)
|
||||||
|
Accrued interest and other adjustments
(3)
|
(618)
|
(572)
|
(46)
|
(671)
|
(658)
|
(13)
|
||||||
|
Debt with third parties (excluding held for sale)
|
(37,227)
|
(24,071)
|
(13,156)
|
(29,463)
|
(22,676)
|
(6,787)
|
||||||
|
Debt classified as held for sale
|
(128)
|
(60)
|
(68)
|
(122)
|
(122)
|
—
|
||||||
|
Debt with third parties including held for sale
|
(37,355)
|
(24,131)
|
(13,224)
|
(29,585)
|
(22,798)
|
(6,787)
|
||||||
|
Intercompany, net
(4)
|
—
|
1,570
|
(1,570)
|
—
|
3,064
|
(3,064)
|
||||||
|
Current financial receivables from jointly-controlled
financial services companies
(5)
|
674
|
524
|
150
|
767
|
647
|
120
|
||||||
|
Debt, net of intercompany, and current financial
receivables from jointly-controlled financial service
companies
|
(36,681)
|
(22,037)
|
(14,644)
|
(28,818)
|
(19,087)
|
(9,731)
|
||||||
|
Derivative financial assets/(liabilities), net and collateral
deposits
(6)
|
222
|
212
|
10
|
20
|
49
|
(29)
|
||||||
|
Financial securities
(7)
|
4,468
|
4,249
|
219
|
6,089
|
5,875
|
214
|
||||||
|
Cash and cash equivalents
|
34,100
|
32,409
|
1,691
|
43,669
|
42,419
|
1,250
|
||||||
|
Cash and cash equivalents classified as held for sale
|
297
|
295
|
2
|
231
|
231
|
—
|
||||||
|
Net financial position
|
2,406
|
15,128
|
(12,722)
|
21,191
|
29,487
|
(8,296)
|
||||||
|
Risk category
|
Category description
|
Risk appetite
|
|
Strategic
|
Risk that may arise from the pursuit of Stellantis’
business plan, from strategic changes in the business
environment, and/or from adverse strategic business
decisions.
|
We are prepared to take risks in a responsible
way that takes our stakeholders’ interests into
account and is consistent with our business
plan.
|
|
Operational
|
Risk relating to internal processes, people and systems or
external events (including legal and reputational risks).
|
We look to mitigate operational risks to the
maximum extent based on cost/benefit
considerations.
|
|
Financial
|
Risk relating to uncertainty of return and the potential for
financial loss due to financial performance.
|
We seek capital market and other transactions
to strengthen our financial position and finance
our operations on a consolidated global basis.
|
|
Compliance
|
Risk of non-compliance with relevant regulations and
laws, internal policies and procedures.
|
We hold ourselves, as well as our employees,
responsible for acting with honesty, integrity
and respect, including complying with our
Code of Conduct, applicable laws and
regulations everywhere we do business.
|
|
Risk
Category
|
Risk
|
Risk Description
|
Control / Mitigating Actions
|
|
Strategic
|
Transition to
Electrification
|
Main risk factors for transition to
electrification include: the evolving nature
of the regulatory environment, the higher
production costs (and corresponding) prices
of EV vehicles that could reduce our
competitive advantage and result in lower
customer appetite and lower profit margin
or in a sharp decrease of the automotive
market share in western countries, the
aggressive competition of new players in
the EV market that are developing with
lower production cost and advanced
technological solutions, and the dependence
of EV (market) on government policies.
|
Cost-reduction strategies to make electric
vehicle’s price more affordable, including
taking a stake in Chinese EV maker Leapmotor
that will give Stellantis further access to
innovative technologies and to an extended
offer.
Execution of battery/EDM roadmap to deliver
performance at the right level.
Secured access to key components and raw
material by entering into long-term agreements
or partnerships.
|
|
Operational
|
Supply Chain
|
Stellantis’ ability to manage critical supplies
to prevent production interruptions, and the
ability to manage limited availability and
increased costs of commodities, energy and
transportation.
|
Actions to mitigate risks related to potential
unavailability of raw materials and critical
components in the time required by production
planning include:
•
assessment of the end-to-end value
chain of supplies to identify possible
critical resources;
•
monitoring of global, political,
environmental and economic events,
to anticipate or identify those that
could lead to supply chain disruption
and implement timely mitigating
actions;
•
developing technical solutions to
reduce dependence on critical raw
materials;
•
monitoring the suppliers’ risk to
mitigate disruption due to any kind of
failure; and
•
strategic partnerships to gain access to
the latest innovations.
|
|
Compliance
|
Compliance
|
The increasing complexity of compliance
requirements in different fields (e.g.,
corporate liability, market regulations,
export controls, anti-bribery, emissions and
vehicle safety, data privacy, human rights,
etc.) puts the organization at risk of non-
compliance, that could result in potential
fines, increased costs, and reputational
damages.
|
Company governance and regular oversight by
top executive management to monitor
compliance with laws and regulatory
requirements and to promote consistency in
approach and process across Stellantis
operations.
Stellantis Code of Conduct clearly and
affirmatively requires employees to report
issues of non-compliance.
Regular training and frequent communication
reinforce the prevention system.
“Stellantis Integrity Helpline” program
encourages employees, contractors, suppliers
and dealers to report any issues that may
concern vehicle safety, emissions or regulatory
compliance.
|
|
Financial
|
Macro-
Economic
Factors
|
The exposure to adverse financial
conditions such as persistent inflation also
impacting labor cost, high interest rates, as
well as repeated increases and volatility in
foreign exchange, raw material and energy
prices, could impact Stellantis’ plans and
profitability and its financial ability to offset
the effects of a major crisis. This risk is
increased by geopolitical instabilities,
continued protectionism and unavailability
of natural resources and energy.
|
Risk is mitigated through:
•
natural and financial hedging
strategies;
•
material substitution and circular
economy strategy;
•
optimization in technical solutions to
minimize the use of critical resources
or find substitutions; and
•
constant monitoring of raw material
market dynamics and of price trends.
|
|
Operational
|
Social
License to
Operate
|
The global presence and the connection
with multiple stakeholders (suppliers,
dealers, unions, governments) may affect
the efficiency of our operations.
|
Maintain continuous contacts with stakeholders
as a channel to inform about Stellantis strategy
and policy.
|
|
Operational
|
Natural
Hazard
|
Global warming increases the likelihood of
major climate events impacting production
or distribution such as flash floods,
tornadoes, hailstorms, heat waves or water
shortages.
|
The analysis of specific climate risks for
Stellantis and critical suppliers’ sites allows an
effective implementation and continuous
monitoring of the prevention process and of the
business continuity and resumption plan at site
level to reduce impact and reinforce resilience.
|
|
Operational
|
Cybersecurity
|
The growing and evolving threats to digital
infrastructure and data security due to
global political tensions, international
conflicts and external social climate may
target Stellantis’ systems and lead to
significant business disruption, loss of
confidential information and competitive
know-how, or breaches of data privacy
resulting in financial and/or reputational
damage.
|
A cybersecurity program, along with
multilayered controls, is in place at Stellantis to
identify and mitigate cyber risks emerging from
the evolving threat landscape. This program has
been developed based on:
•
a comprehensive and thorough
analysis of the potential exposure of
critical company assets, including the
information that must be protected and
the required security level;
•
implementation of policies and
procedures designed to reduce the risk
of attack in the event of a security
breach;
•
plans and procedures established to
neutralize threats and address security
issues effectively; and
•
Frequent employee awareness
campaigns.
|
|
Name
|
Gender
|
Year of Birth
|
Position
|
Nationality
|
Term
(1)
|
Independent
|
||||||
|
John Elkann
|
M
|
1976
|
Chairman and Executive
Director
|
Italy
|
5 years
|
No
|
||||||
|
Robert Peugeot
|
M
|
1950
|
Vice Chairman and Non-
Executive Director
|
France
|
5 years
|
No
|
||||||
|
Henri de Castries
|
M
|
1954
|
Senior Independent Director
and Non-Executive Director
|
France
|
5 years
|
Yes
|
||||||
|
Fiona Clare Cicconi
|
F
|
1966
|
Non-Executive Director
|
UK & Italy
|
4 years
|
Yes
|
||||||
|
Nicolas Dufourcq
|
M
|
1963
|
Non-Executive Director
|
France
|
4 years
|
Yes
|
||||||
|
Ann Frances Godbehere
|
F
|
1955
|
Non-Executive Director
|
Canada & UK
|
4 years
|
Yes
|
||||||
|
Wan Ling Martello
|
F
|
1958
|
Non-Executive Director
|
U.S.
|
4 years
|
Yes
|
||||||
|
Claudia Parzani
|
F
|
1971
|
Non-Executive Director
|
Italy
|
1 year
|
Yes
|
||||||
|
Benoît Ribadeau-Dumas
|
M
|
1972
|
Non-Executive Director
|
France
|
2 years
|
No
|
||||||
|
Jacques de Saint-Exupéry
|
M
|
1957
|
Non-Executive Director
|
France
|
4 years
|
No
|
|
Climate
Change
|
Human
Rights
|
Risk
Management
|
Cyber
security
|
New
Business
Model
|
Industry
|
Corporate
Social
Responsibility
|
Governance
|
Financial
and
Accounting
|
Board
memberships
|
|
|
John Elkann
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
4
|
|||
|
Robert Peugeot
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
4
|
|||
|
Henri de
Castries
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
3
|
|||
|
Fiona Clare
Cicconi
|
✓
|
✓
|
✓
|
✓
|
—
|
|||||
|
Nicolas
Dufourcq
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
2
|
|||
|
Ann Frances
Godbehere
|
✓
|
✓
|
✓
|
✓
|
✓
|
2
|
||||
|
Wan Ling
Martello
|
✓
|
✓
|
✓
|
✓
|
✓
|
3
|
||||
|
Claudia Parzani
|
✓
|
✓
|
✓
|
2
|
||||||
|
Benoît
Ribadeau-
Dumas
|
✓
|
✓
|
5
|
|||||||
|
Jacques de
Saint-Exupéry
|
✓
|
—
|
|
Directors Owning Stellantis Common Shares
|
Shares
|
Percent of
Class
|
||
|
John Elkann
|
1,152,462
|
—
%
|
||
|
Robert Peugeot
|
15,000
|
—
%
|
||
|
Henri de Castries
|
21,000
|
—
%
|
||
|
Fiona Clare Cicconi
|
11,662
|
—
%
|
||
|
Nicolas Dufourcq
|
—
|
—
%
|
||
|
Ann Frances Godbehere
|
9,650
|
—
%
|
||
|
Wan Ling Martello
|
—
|
—
%
|
||
|
Claudia Parzani
|
—
|
—
%
|
||
|
Benoît Ribadeau-Dumas
|
—
|
—
%
|
||
|
Jacques de Saint-Exupéry
|
1,000
|
—
%
|
|
Year of Birth
|
Name
|
Gender
|
Nationality
|
|||
|
1976
|
J. Elkann
|
M
|
Italian
|
|||
|
1950
|
R. Peugeot
|
M
|
French
|
|||
|
1954
|
H. De Castries
|
M
|
French
|
|||
|
1966
|
F. C. Cicconi
|
F
|
British – Italian
|
|||
|
1963
|
N. Dufourcq
|
M
|
French
|
|||
|
1955
|
A. F. Godbehere
|
F
|
Canadian - British
|
|||
|
1958
|
W. L. Martello
|
F
|
U.S.
|
|||
|
1971
|
C. Parzani
(1)
|
F
|
Italian
|
|||
|
1972
|
B. Ribadeau-Dumas
|
M
|
French
|
|||
|
1957
|
J. De Saint-Exupery
|
M
|
French
|
|||
|
1972
|
K. Scott
(2)
|
M
|
U.S.
|
|
Name
|
Meeting Board of
Directors
|
Audit Committee
|
ESG Committee
|
Remuneration
Committee
|
|
John Elkann
|
8/8
|
|||
|
Carlos Tavares
(*)
|
6/7
|
|||
|
Robert Peugeot
|
8/8
|
4/4
|
||
|
Henri de Castries
|
8/8
|
12/12
|
3/3
|
4/4
|
|
Fiona Clare Cicconi
|
8/8
|
4/4
|
3/3
|
4/4
|
|
Nicolas Dufourcq
|
8/8
|
3/3
|
||
|
Ann Frances Godbehere
|
8/8
|
12/12
|
||
|
Wan Ling Martello
|
7/8
|
10/12
|
3/4
|
|
|
Claudia Parzani
|
7/7
|
8/8
|
1/1
|
|
|
Benoît Ribadeau-Dumas
|
8/8
|
3/3
|
4/4
|
|
|
Jacques de Saint-Exupery
|
8/8
|
|||
|
Kevin Scott
|
1/1
|
2/2
|
|
Fixed Compensation
|
Variable Compensation
|
||||||||
|
Directors of
Stellantis
|
Office
Held
|
Year
|
Base
Salary/Fees
|
Fringe
benefits
|
Short-Term
Incentive
|
Long-Term
Incentive
|
Post
Retirement
Benefit
Expense
|
Other
Compensation
|
Total
Remuneration
|
|
TAVARES,
Carlos
|
CEO
|
2024
|
€2,000,000
|
€71,224
|
€—
|
€20,514,494*
|
€500,000
|
€—
|
€23,085,718
|
|
2023
|
€2,000,000
|
€634,697
|
€5,786,800
|
€26,125,828
|
€1,946,700
|
€—
|
€36,494,025
|
||
|
Remuneration Provision
|
Remuneration Element
|
Remuneration Elements from Settlement Agreement
|
|
Severance Amount
(pursuant to Dutch Civil Code)
|
€ 2,000,000
|
€2,000,000 to be paid in 2025
|
|
2021-2025 Transformation Incentive*
|
> Three milestones evaluated in 2024 with
potential payout of €30 million*
> Payment of one milestone (€10m) was made in
March 2024
|
> Payment of second milestone (€10m); to be paid in 2025
> Third milestone was evaluated and not paid
|
|
Shareholder Return Incentive*
|
> 1,000,000 Performance Share Units (PSUs) at
target performance as approved by Shareholders in
2021 - to be distributed in January 2026 based on
TSR performance
> TSR performance resulted with a distribution of
200% of target - 2,000,000 PSUs
|
> To receive 800,000 shares in January 2026***
> 1,200,000 shares were forfeited
|
|
LTI Grants - 2022, 2023 & 2024
(2023 & 2024 LTI based on target
performance)
|
Granted the following number of Share Units:
2022 LTI: 928,870 (696,650 PSUs + 232,200
RSUs)
2023 LTI: 744,417 PSUs
2024 LTI: 497,247 PSUs
|
Under the terms of the LTI plan, eligible to receive a
prorated share of units based on employment during the
respective performance period:
2022 LTI: 610,292 (410,327 PSUs + 199,965 RSUs)
2023 LTI: 496,303 PSUs**
2024 LTI: 165,750 PSUs**
|
|
Total Shares: 2,170,534
|
Total Shares: 1,272,345***
|
|
Principles of Executive Remuneration
|
|
|
Alignment with Stellantis Strategy
|
Compensation is strongly
linked to the achievement
of the Company’s disclosed
performance targets.
|
|
Pay for Performance
|
Must
reinforce our performance-driven culture and principles of meritocracy
.
Majority of pay is
linked directly to Company performance
through both short
and long-term variable pay.
|
|
Competitiveness
|
Compensation will be
competitive
against the comparable
global
market and set in
a manner to
attract, retain and motivate
expert leaders and highly qualified
executives. Considering competitiveness across both the European and U.S. talent
market is essential given our global footprint.
|
|
Creating Long-term Shareholder
Value
|
Performance targets triggering any variable compensation payment should
align
with the interests of shareholders and other stakeholders
.
|
|
Compliance
|
Compensation policies and practices are
designed to comply
with applicable laws
and corporate governance requirements.
|
|
Risk Prudence
|
The compensation structure and design should
avoid incentives that encourage
unnecessary or excessive risks
that could threaten the Company’s value.
|
|
Remuneration Element
|
Key Feature
|
Alignment to Strategy and
Shareholder Interests
|
|
Base Salary
|
Market-based fixed cash compensation
set competitively to large global
automobile manufacturers with the peer
group.
|
Set at a level to attract, motivate and
retain the best talents in global and/or
regional markets.
|
|
Short-Term Incentive Plan -
Stellantis Annual Incentive Plan
(“SAIP”)
|
Paid annually in cash; the CEO’s target
opportunity is 200% of base salary and
maximum opportunity is 400% of base
salary. Board Chair is not eligible.
|
Incentivize delivery of performance
against our pre-established and
challenging annual strategic and
financial goals.
|
|
LTI Plan
|
100% Performance Share Units
(PSUs): Conditional rights on ordinary
shares, with amounts earned subject to
Company performance and a three-year
vesting schedule.
|
Incentivize delivery of financial
performance and creation of long-term
sustainable value; demonstrates long-
term alignment with shareholder
interests. PSUs are 100% at-risk and
contingent upon Stellantis’
performance - no amounts are
guaranteed.
|
|
Share Ownership and Retention
Guidelines
|
Executive Directors:
Six (6) x Annual Base Salary
Required to retain one hundred percent
(100%) of net, after-tax shares of
Common stock issued upon vesting and
settlement of any equity awards granted
until the fifth (5th) anniversary of the
grant date of such award.
Shares owned outright and any
unvested Restricted Stock Units
(RSUs) are counted for purposes of
satisfying the guideline. Unvested
PSUs are not considered.
|
Establishes long-term alignment with
shareholders; promotes focus on
management of company risks.
|
|
Retirement Benefits
|
Defined contribution retirement
savings plan that is available to the
CEO and all employees in the country
of employment. The Chairman
participates in a retiree health care
benefit plan.
|
Provides appropriate retirement savings
designed to be competitive in the
relevant market.
|
|
Other Benefits & Allowances
|
Executive Directors may receive usual
and customary fringe benefits such as
severance, company vehicles, security,
medical insurance, tax preparation,
financial consulting and tax
equalization.
|
Recognizes competitive practices.
|
|
U.S. Companies
|
European Companies
|
||
|
•
Boeing
|
•
General Dynamics
|
•
Airbus
|
•
Renault
|
|
•
Caterpillar
|
•
General Electric
|
•
ArcelorMittal
|
•
Siemens
|
|
•
Chevron
|
•
General Motors
|
•
BASF
|
•
Volvo Cars
|
|
•
Deere
|
•
Honeywell
|
•
BMW
|
•
TotalEnergies SE
|
|
•
Exxon Mobil
|
•
Lockheed Martin
|
•
Continental
|
•
Volkswagen
|
|
•
Ford
|
•
Raytheon Technologies
|
•
Mercedes-Benz
(formerly Daimler)
|
•
Volvo
|
|
What we do:
|
What we do not do:
|
|||
|
•
Pay for performance by structuring a significant
percentage of target compensation in the form of
variable, at risk compensation within Stellantis
|
•
We do not offer remuneration which encourages
our Executive Directors and non-Executive
Directors to take any unnecessary or excessive
risks or to act in their own interests
|
|||
|
•
Predetermined stretch performance goals for
incentive pay programs
|
•
We do not reward for performance below
threshold
|
|||
|
•
We align goals and values organization-wide
through incentive pay and rigorous performance
management
|
•
We do not have excessive pay programs
|
|||
|
•
Incorporate ESG goals into our short-term and
long-term incentive plans
|
•
We do not allow hedging, pledging or short-
selling of our securities
|
|||
|
•
Market comparison of Executive Director and non-
Executive Director remuneration against relevant
peers
|
•
We do not pay out guaranteed bonuses
|
|||
|
•
Conduct a rigorous and detailed analysis of CEO
pay and Company performance against our peers
|
•
We have no excessive perquisites
|
|||
|
•
We consider pay ratios within the Company in
establishing Executive Directors’ pay
|
||||
|
•
Use of an independent compensation consultant
reporting directly to the Remuneration Committee
|
||||
|
•
We have robust stock ownership and share
retention guidelines
|
||||
|
•
We have clawback policies incorporated into our
incentive plans
|
||||
|
•
“Double-trigger” vesting of equity awards upon a
change of control
|
||||
|
Fixed Remuneration
|
Variable Remuneration
|
|||||||||||||
|
Directors of
Stellantis
|
Office
Held
|
Year
|
Base
salary/
Fees
|
Fringe benefits
|
Short-term
incentive
|
Long-term
incentive
|
Post
Retirement
Benefits
Expense
|
Other
Compensation
|
Total
Remuneration
|
Proportion of
Fixed
Remuneration
|
Proportion of
Variable
Remuneration
|
|||
|
ELKANN John
Philipp
|
Chairman
|
2024
|
€
922,386
|
€
721,830
|
(1)
|
€
1,153,062
|
(2)
|
€
2,797,278
|
59%
|
41%
|
||||
|
2023
|
924,404
|
684,230
|
3,214,886
|
4,823,520
|
||||||||||
|
TAVARES,
Carlos
|
CEO
|
2024
|
2,000,000
|
71,224
|
(1)
|
€
—
|
20,514,494
|
(3)
|
€
500,000
|
23,085,718
|
9%
|
91%
|
||
|
2023
|
2,000,000
|
634,697
|
5,786,800
|
26,125,828
|
1,946,700
|
36,494,025
|
||||||||
|
PEUGEOT,
Robert
|
Vice
Chairman
|
2024
|
205,000
|
15,405
|
(4)
|
220,405
|
100%
|
—%
|
||||||
|
2023
|
205,000
|
11,927
|
216,927
|
|||||||||||
|
AGNELLI,
Andrea (5)
|
Director
|
2024
|
—
|
—
|
—
|
|||||||||
|
2023
|
60,000
|
2,644
|
62,644
|
|||||||||||
|
CASTRIES,
Henri de
|
Director
|
2024
|
275,000
|
14,829
|
(4)
|
289,829
|
100%
|
—%
|
||||||
|
2023
|
275,000
|
11,924
|
286,924
|
|||||||||||
|
CICCONI,
Fiona Clare
|
Director
|
2024
|
215,000
|
23,046
|
(4)
|
238,046
|
100%
|
—%
|
||||||
|
2023
|
215,632
|
18,846
|
234,478
|
|||||||||||
|
DUFOURCQ,
Nicolas (6)
|
Director
|
2024
|
—
|
—
|
—
|
|||||||||
|
2023
|
—
|
—
|
—
|
|||||||||||
|
GODBEHERE,
Ann Frances
|
Director
|
2024
|
225,000
|
—
|
225,000
|
100%
|
—%
|
|||||||
|
2023
|
225,000
|
510
|
225,510
|
|||||||||||
|
MARTELLO,
Wan Ling
|
Director
|
2024
|
220,000
|
25,960
|
(4)
|
245,960
|
100%
|
—%
|
||||||
|
2023
|
220,000
|
25,960
|
245,960
|
|||||||||||
|
PARZANI,
Claudia (7)
|
Director
|
2024
|
152,390
|
2,557
|
(4)
|
154,947
|
100%
|
—%
|
||||||
|
RIBADEAU-
DUMAS,
Benoit (8)
|
Director
|
2024
|
—
|
—
|
||||||||||
|
2023
|
||||||||||||||
|
SAINT-
EXUPERY,
Jacques
|
Director
|
2024
|
200,000
|
—
|
200,000
|
100%
|
—%
|
|||||||
|
2023
|
200,000
|
—
|
200,000
|
|||||||||||
|
SCOTT, Kevin
(9)
|
Director
|
2024
|
59,698
|
10,891
|
(4)
|
70,589
|
100%
|
—%
|
||||||
|
2023
|
205,000
|
25,960
|
230,960
|
|||||||||||
|
4,322,084
|
883,185
|
—
|
21,667,556
|
500,000
|
—
|
27,372,825
|
||||||||
|
Executive Director
|
2024 Annual Base Salary
|
|
John Elkann, Chairman
|
$1,000,000
|
|
Carlos Tavares, Chief Executive Officer
|
€2,000,000
|
|
Executive Director
|
2024 Annual Incentive Target Opportunity
(as a % of base pay)
|
||
|
Threshold
|
Target
|
Maximum
|
|
|
John Elkann, Board Chair
|
Not Eligible
|
Not Eligible
|
Not Eligible
|
|
Carlos Tavares, Chief Executive Officer
|
100%
|
200%
|
400%
|
|
Metric:
|
Weighting:
|
|
Adjusted Operating Income (“AOI”)
|
32.5%
|
|
Industrial Free Cash Flow (excludes FinCo)
|
32.5%
|
|
ESG: Safety (Lost Time Injury Rate)
|
8.0%
|
|
ESG: BEV Market Share Europe
|
6.0%
|
|
ESG: LEV Mix USA (Production)
|
6.0%
|
|
Quality: Failure Rate 3MS kppm
|
7.0%
|
|
Quality: Customer Satisfaction NPS-NV&AFS (Average)
|
4.0%
|
|
Quality: Total Warranty Cost (Incident KPI)
|
4.0%
|
|
SAIP Performance Metric
|
Weight
|
Threshold
|
Target
|
Maximum
|
Actual
|
SAIP Result
|
|
Adjusted Operating Income
|
32.5%
|
10.0%
|
10.5%
|
11.6%
|
5.5%
|
0%
|
|
Industrial Free Cash Flow
|
32.5%
|
€6.0bn
|
€8.0bn
|
€11.7bn
|
€-6bn
|
0%
|
|
ESG: Safety
|
8%
|
1.1
|
0.95
|
.085
|
.084
|
200%
|
|
Low Emissions Vehicles
|
||||||
|
ESG: BEV Market Share - EU
|
6.0%
|
14.2%
|
Parity -3pp
|
Parity
|
12.0%
|
0%
|
|
ESG: LEV Mix - U.S. Production
|
6.0%
|
13.5%
|
21%
|
23%
|
8.7%
|
0%
|
|
Quality – 3 metrics
|
||||||
|
Failure Rate 3MIS kppm
|
7.0%
|
ND*
|
ND*
|
ND*
|
ND*
|
0%
|
|
Customer Satisfaction – NPS NV
|
4.0%
|
ND*
|
ND*
|
ND*
|
ND*
|
64%
|
|
Customer Satisfaction – NPS AFS
|
4.0%
|
ND*
|
ND*
|
ND*
|
ND*
|
74%
|
|
Total Payout Percentage:
|
21.52%
|
|||||
|
Total Payout Percentage
(recognizing Payout Trigger):
|
0.00%
|
|||||
|
Base
Salary
|
Annual Cash Bonus Range
|
Actual 2024
SAIP Payout
|
||||
|
Below
Threshold
|
Threshold
|
Target
|
Maximum
|
|||
|
Carlos Tavares
|
€2,000,000
|
€ 0
|
€2,000,000
|
€4,000,000
|
€8,000,000
|
€0
|
|
Executive Director
|
2023 Long-Term Incentive Opportunity
|
|
|
Target Opportunity
|
Maximum Opportunity
|
|
|
John Elkann, Board Chair
|
300% of base salary
|
390% of base salary
|
|
Carlos Tavares, Chief Executive Officer
|
600% of base salary
|
780% of base salary
|
|
2022-2024 LTI PSU Metrics
|
||
|
Measure
|
Weighting
|
How performance is calculated
|
|
Relative Total Shareholder Return
|
40%
|
Relative TSR performance as compared to peer group of
companies. over a 3-year period
|
|
Synergies (less implementation costs)
|
40%
|
Cumulative cash synergies net of implementation costs
realized over the three-year period. Maximum payout for
this metric is 100%.
|
|
The CO
2
emissions reduction metric (weighted at 20% of the LTI) has two components equally weighted:
|
||
|
CAFE Compliance
|
10%
|
Must be compliant in each year of the 3-year period with
the Europe Corporate Average Fuel Economy (CAFE).
Failure to comply in any one year will result in no payout
for this metric.
|
|
Electrification of Vehicle Nameplates
|
10%
|
Projected number of EV nameplates at the end of a 3-year
period. Maximum payout for this metric is 100%.
|
|
2023-2025 & 2024-2026 LTI PSU Metrics
|
||
|
Measure
|
Weighting
|
How performance is calculated
|
|
Relative Total Shareholder Return
|
30%
|
Relative TSR performance as compared to peer group of
companies. over a 3-year period; no payout below median
performance.
|
|
Adjusted operating income (3-yr period)
|
40%
|
Cumulative cash synergies net of implementation costs
realized over the three-year period. Maximum payout for
this metric is 100%.
|
|
Electrification of Vehicle Nameplates
|
30%
|
Projected number of EV nameplates at the end of a 3-year
period. Maximum payout for this metric is 100%.
|
|
2022-2024 LTI
TSR Payout Scale
|
2023-2025 LTI & 2024-2026 LTI
TSR Payout Scale
|
|||
|
Stellantis Rank
|
Payout % of Target
|
Stellantis Rank
|
Payout % of Target
|
|
|
1st
|
200%
|
1st
|
200%
|
|
|
2nd
|
175%
|
2nd
|
180%
|
|
|
3rd
|
150%
|
3rd
|
160%
|
|
|
4th
|
125%
|
4th
|
140%
|
|
|
5th
|
100%
|
5th
|
120%
|
|
|
6th
|
75%
|
6th
|
100%
|
|
|
7th
|
50%
|
7th
|
—%
|
|
|
8th
|
25%
|
8th
|
—%
|
|
|
9th
|
—%
|
9th
|
—%
|
|
|
10th
|
—%
|
10th
|
—%
|
|
|
11th
|
—%
|
11th
|
—%
|
|
|
12th
|
—%
|
12th
|
—%
|
|
|
Executive Director
|
2022-2024 Long-Term Incentive PSUs Awarded
|
|
|
PSUs awarded in 2022
|
PSUs to be distributed in May 2025
(based on 58.93% performance)*
|
|
|
John Elkann, Board Chair
|
164,840
|
97,091
|
|
Carlos Tavares, Chief Executive Officer
|
696,650
|
410,327
|
|
Beginning in 2021, Stellantis launched its bold strategy to transform itself to a
sustainable mobility tech company – emphasizing the electrification and software of its
vehicles, followed with its ambitious DARE FORWARD 2030 plan for carbon net zero
in 2038 with single-digit percentage compensation of the remaining emissions.
Given the challenges that the automotive industry is facing with the
transformation in global mobility, technology and the electrification of vehicles, and in
recognition of Mr. Tavares’ essential role in leading Stellantis through the merger, on
June 30, 2021, as provided under the terms of the Remuneration Policy, the
Remuneration Committee recommended, and the Board approved, a one-time
transformation incentive for the CEO. The design of the incentive, through the
Remuneration Committee’s comprehensive and thoughtful consideration, reflects direct
alignment between the Company’s direction of delivering value to shareholders through
the critical merger and integration period while successfully positioning the Company as
a global leader in the innovation of electrification of mobility in the industry. It was for
this reason that the one-time incentive was defined and awarded in 2021 (after the
creation of Stellantis from the merger) - to lock-in long-term goals over a critical five-
year performance period.
|
€ 30 billion
in Company
investment of
electrification and
technology
To be a leader in
the industry
Maximum payout (meeting
all seven milestones) of the
Transformation Incentive is 0.167% of
the investment
|
|
1.
|
Milestone Validation
|
•
Company’s Human Resources and the business owner responsible for the
milestone confirms that the milestone was achieved.
•
Minutes/documentation necessary to support achievement, subject to internal
audit verification.
|
|
2.
|
Milestone Assessment
|
•
Detailed information about milestone achievement provided to Remuneration
Committee for review and assessment.
|
|
3.
|
Committee Validation
|
•
Committee makes determination that milestone was successfully achieved
(vesting of the award).
|
|
4.
|
Incentive Payout
|
•
Incentive is settled in cash no later than sixty days from vesting event.
•
CEO must remain in continuous employment throughout the achievement of
each milestone.
|
|
Innovative Milestone Achieved
during the 5-year Performance Period
|
Cash Award (percentage of Target Value)
|
|
0-1
|
0%
|
|
2
|
20%
|
|
3
|
40%
|
|
4
|
80%
|
|
5
|
120%
|
|
6
|
160%
|
|
7
|
200%
|
|
Milestone Achieved
|
Significance to Long-Term Strategy
|
Stellantis Sustainability and Future
|
|
European LEV sales mix at 15%
(achieved in 2022)
|
•
European LEV sales mix < 9%
prior to 2021
•
Industry is transforming away
from carbon-emitting internal
combustion engines
|
•
Beginning of the journey to
become a global leader in
electrification and mobility
•
Drive Stellantis in the LEV (BEV/
PHEV) competition to be a top
player in industry
|
|
First start of production of e-motors
made at Nidec PSA E-motors (NPE)
(achieved in 2023)
|
•
Starting from ground up – modify
plants to produce new technology
and retraining employees
•
Cornerstone for e-components
vertical integration (not outsource
like competition)
•
Provides highest efficiency at
competitive costs
•
Over €93M of industrial
investments to date
|
•
Stellantis Trémery plant first
facility to produce electric motors
•
Aims to drive electrification
growth while also meeting the
needs of other automakers
|
|
First start of production of eDCT
electrified
(achieved in 2023)
|
•
Starting from ground up – modify
plants to produce new technology
and retraining employees
•
Cornerstone for e-components
vertical integration insource (not
outsource like competition)
•
Provides broader availability of
affordable electrified powertrains
on global market
•
Over €57M of industrial
investments to date
|
•
Stellantis Metz site ramping up
production of 600,000 electrified
dual-clutch gearboxes per year
•
Supply mild Hybrid Electric
Vehicles and PHEV
•
Solution will gradually be
extended to all brand models in
Europe to reduce CO
2
emissions
|
|
Achieve over 15 million Over the Air
Software update of Vehicles over three
years beginning 2021
(achieved in 2024)
|
•
Increase the attractiveness and
residual values of our vehicles
•
Controls and reduces the number
of SW versions in operation
•
Creates revenue opportunity over
the life cycle of the vehicle, an in
car communication channel for
CRM and cross selling
•
Meaningful warranty cost
avoidance and customer
satisfaction achieved avoiding
physical recalls
|
•
Additional revenue opportunities
over the vehicle’s life cycle
|
|
Name of
Director,
Position
|
Specification
of Plan
|
Performance
Period
|
Grant
Date
|
Number of
Units
Granted
|
Fair Value
at
Grant Date
(1)
|
Vesting
Date
|
End of
Holding
Period
|
Opening
Balance -
January
01, 2024
|
Shares
Granted
|
Shares
Cancelled /
Forfeited
(2)
|
Shares
Vested
(3)
|
Closing
Balance
|
Long-
Term
Incentive
Expense
|
|
ELKANN, John
Phillip,
Chairman
|
2021 LTI RSU
|
2021-2023
|
April 15,
2021
|
42,580
|
€ 622,904
|
April 15,
2024
|
May 1,
2026
|
42,580
|
—
|
42,580
|
—
|
€8,103
|
|
|
2021 LTI PSU
|
2021-2023
|
April 15,
2021
|
127,900
|
€ 1,871,053
|
April 15,
2024
|
May 1,
2026
|
127,900
|
51,160
|
2,558
|
176,502
|
—
|
€25,535
|
|
|
2022 LTI RSU
|
2022-2024
|
May 15,
2022
|
54,950
|
€ 580,959
|
May 15,
2025
|
May 15,
2027
|
54,950
|
—
|
—
|
54,950
|
€240,392
|
||
|
2022 LTI PSU
|
2022-2024
|
May 15,
2022
|
164,840
|
€ 1,686,462
|
May 15,
2025
|
May 15,
2027
|
164,840
|
—
|
—
|
164,840
|
€689,899
|
||
|
2023 LTI PSU
|
2023 - 2025
|
May 1,
2023
|
169,773
|
€ 2,138,008
|
May 1,
2026
|
May 1,
2028
|
169,773
|
—
|
—
|
169,773
|
€82,156
|
||
|
2024 LTI PSU
|
2024 - 2026
|
May 15,
2024
|
115,886
|
€1,182,036
|
May 15,
2027
|
May 15,
2029
|
—
|
115,886
|
—
|
115,886
|
€106,977
|
||
|
TAVARES,
Carlos CEO
|
2021 LTI RSU
|
2021-2023
|
April 15,
2021
|
204,180
|
€ 2,956,526
|
May 15,
2024
|
May 15,
2026
|
204,180
|
—
|
204,180
|
—
|
€38,747
|
|
|
2021 LTI PSU
|
2021-2023
|
April 15,
2021
|
612,700
|
€ 9,484,596
|
May 15,
2024
|
May 15,
2026
|
612,700
|
245,080
|
12,254
|
845,526
|
—
|
€122,700
|
|
|
2021 CEO
PSU
(4)
|
2021-2026
|
June 28,
2021
|
1,000,000
|
€ 19,560,000
|
January
17, 2026
|
January
17, 2028
|
1,000,000
|
—
|
200,000
|
—
|
800,000
|
€4,885,883
|
|
|
2021 LTI
RSU
(5)
|
2021-2023
|
October 1,
2021
|
10,190
|
€ 143,068
|
October 1,
2024
|
May 1,
2026
|
10,190
|
—
|
10,190
|
—
|
€38,543
|
||
|
2022 LTI RSU
|
2022-2024
|
May 15,
2022
|
232,220
|
€ 2,584,366
|
May 15,
2025
|
May 15,
2027
|
232,220
|
—
|
32,255
|
—
|
199,965
|
€903,225
|
|
|
2022 LTI PSU
|
2022-2024
|
May 15,
2022
|
696,650
|
€ 7,502,483
|
May 15,
2025
|
May 15,
2027
|
696,650
|
—
|
—
|
696,650
|
€3,010,424
|
||
|
2023 LTI PSU
|
2023 - 2025
|
May 1,
2023
|
744,417
|
€ 9,374,692
|
May 1,
2026
|
May 1,
2028
|
744,417
|
—
|
248,114
|
—
|
496,303
|
€678,200
|
|
|
2024 LTI PSU
|
2024 - 2026
|
May 15,
2024
|
497,247
|
€5,071,920
|
May 15,
2027
|
May 15,
2029
|
—
|
497,247
|
331,497
|
—
|
165,750
|
€836,772
|
|
Non-executive Director Remuneration
|
|
|
Annual cash retainer:
|
€ 200,000
|
|
Additional retainer for Senior Independent Director:
|
€ 50,000
|
|
Additional retainer for Audit Committee Chair:
|
€ 25,000
|
|
Additional retainer for Audit Committee membership:
|
€ 10,000
|
|
Additional retainer for other Committee Chairs:
|
€ 10,000
|
|
Additional retainer for other Committee membership:
|
€ 5,000
|
|
Employees excluding Executive Directors
|
2024
|
2023
|
2022
|
2021
|
2020(1)
|
5 years
average
|
||||||
|
Personnel cost (€ billion)
|
|
19.1
|
18.2
|
17.1
|
10.3
|
16.4
|
||||||
|
Average number of employees
|
|
271,292
|
282,926
|
292,432
|
191,703
|
259,494
|
||||||
|
Average employee compensation (€)
|
65,993
|
70,404
|
64,328
|
58,475
|
53,729
|
62,586
|
|
2024
|
2023
|
2022
|
2021
(1)
|
2020
(2)
|
5 years
average
|
|||||||
|
CEO compensation (€)
|
23,085,718
|
36,494,025
|
23,459,006
|
17,453,507
|
11,729,558
|
22,444,363
|
||||||
|
Average employee compensation (€)
|
65,993
|
70,404
|
64,328
|
58,475
|
53,729
|
62,586
|
||||||
|
CEO Pay Ratio
|
350*
|
518
*
|
365
|
298
|
218
|
350
|
|
Company Performance
|
2024
|
2023
|
2022
|
2021
|
2020
(1)
|
|||||||||||||||
|
Net revenues (€ million)
|
€
|
€189,544
|
€179,592
|
€149,419
|
€86,676
|
|||||||||||||||
|
Net profit/(loss) from continuing operations (€ million)
|
|
18,625
|
16,779
|
13,218
|
24
|
|||||||||||||||
|
Diluted earnings/(loss) per share from continuing
operations (€)
|
€
|
€5.94
|
€5.31
|
€4.19
|
€0.02
|
|||||||||||||||
|
Director
|
Position
|
2024
|
2023
|
2022
|
2021
|
2020
(1)
|
||||||
|
ELKANN,
John Philipp
|
Chairman
|
€ 2,797,278
|
€ 4,823,519
|
€ 5,850,051
|
€ 7,884,085
|
€ 2,391,177
|
||||||
|
TAVARES,
Carlos
|
Former CEO
|
23,085,718
|
36,494,025
|
23,459,006
|
19,153,507
|
|||||||
|
PEUGEOT,
Robert
|
Director
|
220,405
|
216,927
|
219,595
|
203,782
|
|||||||
|
AGNELLI,
Andrea
|
Director
|
-
|
62,644
|
223,022
|
226,135
|
45,888
|
||||||
|
CASTRIES,
Henri de
|
Director
|
289,829
|
286,294
|
290,010
|
273,725
|
|||||||
|
CICCONI, Fiona
Clare
|
Director
|
238,046
|
234,478
|
227,611
|
208,061
|
|||||||
|
DUFOURCQ,
Nicolas
|
Director
|
-
|
-
|
-
|
-
|
|||||||
|
GODBEHERE,
Ann Frances
|
Director
|
225,510
|
225,510
|
228,106
|
228,458
|
|||||||
|
MARTELLO,
Wan Ling
|
Director
|
245,960
|
245,960
|
234,440
|
221,546
|
|||||||
|
PARZANI,
Claudia
|
Director
|
154,947
|
||||||||||
|
RIBADEAU-
DUMAS, Benoit
|
Director
|
-
|
-
|
|||||||||
|
SAINT-
EXUPERY,
Jacques
|
Director
|
200,000
|
200,000
|
201,853
|
198,436
|
|||||||
|
SCOTT,
Kevin
|
Director
|
70,589
|
230,960
|
218,702
|
203,498
|
|||||||
|
MARCHIONNE,
Sergio
|
Former CEO
|
26,080,867
|
||||||||||
|
MANLEY,
Michael
|
Former CEO
|
51,184,773
(2)
|
305,876
|
11,728,558
|
||||||||
|
PALMER,
Richard
|
Former CFO
|
345,686
(3)
|
14,766,580
|
4,471,542
|
||||||||
|
ABBOTT, John
|
Former Director
|
8,456
|
43,775
|
|||||||||
|
BRANDOLINI
D'ABBA,
Tiberto
|
Former Director
|
9,169
|
44,691
|
|||||||||
|
EARLE,
Glenn
|
Former Director
|
8,387
|
71,635
|
|||||||||
|
MARS,
Valerie
|
Former Director
|
11,872
|
60,903
|
|||||||||
|
THOMPSON,
Ronald L.
|
Former Director
|
14,611
|
58,231
|
|||||||||
|
VOLPI,
Michelango A.
|
Former Director
|
12,198
|
52,369
|
|||||||||
|
WHEATCROFT,
Patience
|
Former Director
|
8,723
|
59,690
|
|||||||||
|
ZEGNA,
Emenegildo
|
Former Director
|
24,479
|
68,037
|
|
Average employee compensation
|
2024
|
2023
|
2022
|
2021
|
2020
(1)
|
||||||||||||||||
|
Average employee compensation
|
€
|
65,993
|
€
|
70,404
|
€
|
64,328
|
€
|
58,475
|
€
|
53,729
|
|||||||||||
|
Page
|
||
|
|
||
|
Years ended December 31,
|
|||||||
|
Note
|
2024
|
2023
|
2022
|
||||
|
Net revenues
|
4
|
€
|
€
|
€
|
|||
|
Cost of revenues
|
|
|
|
||||
|
Selling, general and other costs
|
|
|
|
||||
|
Research and development costs
|
5
|
|
|
|
|||
|
Gains/(losses) on disposal of investments
|
(
|
|
|
||||
|
Restructuring costs
|
|
|
|
||||
|
Share of the profit/(loss) of equity method investees
|
12
|
(
|
|
|
|||
|
Operating income/(loss)
|
|
|
|
||||
|
Net financial expenses/(income)
|
6
|
(
|
(
|
|
|||
|
Profit/(loss) before taxes
|
|
|
|
||||
|
Tax expenses/(benefit)
|
7
|
(
|
|
|
|||
|
Net profit/(loss)
|
€
|
€
|
€
|
||||
|
Net profit/(loss) attributable to:
|
|||||||
|
Owners of the parent
|
€
|
€
|
€
|
||||
|
Non-controlling interests
|
|
|
(
|
||||
|
€
|
€
|
€
|
|||||
|
Earnings per share:
|
29
|
||||||
|
Basic earnings per share
|
€
|
€
|
€
|
||||
|
Diluted earnings per share
|
€
|
€
|
€
|
||||
|
Years ended December 31,
|
|||||||
|
Note
|
2024
|
2023
|
2022
|
||||
|
Consolidated profit/(loss) for the period
|
€
|
€
|
€
|
||||
|
Fair value remeasurement to cash flow hedges
|
|
(
|
(
|
||||
|
of which, reclassified to the income statement
|
|
|
(
|
||||
|
of which, recognized in equity during the period
|
|
(
|
(
|
||||
|
Gains and losses from remeasurement of financial assets
|
|
|
|
||||
|
of which, recognized in equity during the period
|
|
|
|
||||
|
Exchange differences on translating foreign operations
|
|
(
|
|
||||
|
Income tax (expenses)/benefit
|
(
|
|
|
||||
|
Share of Other comprehensive income/(loss) for equity method investees
|
|
(
|
(
|
||||
|
Amounts to be potentially reclassified to profit or loss
|
28
|
|
(
|
|
|||
|
Actuarial gains and losses on defined benefit pension obligations
|
(
|
(
|
|
||||
|
Share of Other comprehensive income/(loss) for equity method investees
|
(
|
|
(
|
||||
|
Income tax (expenses)/benefit
|
|
|
(
|
||||
|
Amounts not to be reclassified to profit or loss
|
28
|
(
|
(
|
|
|||
|
TOTAL CONSOLIDATED COMPREHENSIVE INCOME/(LOSS)
FOR THE PERIOD
|
€
|
€
|
€
|
||||
|
of which, attributable to equity holders of the parent
|
€
|
€
|
€
|
||||
|
of which, attributable to non-controlling interests
|
€
|
€
|
€
(
|
||||
|
At December 31,
|
|||||
|
Note
|
2024
|
2023
|
|||
|
Assets
|
|||||
|
Goodwill and intangible assets with indefinite useful lives
|
9
|
€
|
€
|
||
|
Other intangible assets
|
10
|
|
|
||
|
Property, plant and equipment
|
11
|
|
|
||
|
Equity method investments
|
12
|
|
|
||
|
Non-current financial assets
|
13
|
|
|
||
|
Other non-current assets and prepaid expenses
|
16
|
|
|
||
|
Deferred tax assets
|
7
|
|
|
||
|
Tax receivables
|
16
|
|
|
||
|
Total Non-current assets
|
|
|
|||
|
Inventories
|
14
|
|
|
||
|
Assets sold with a buy-back commitment
|
|
|
|||
|
Trade receivables
|
16
|
|
|
||
|
Tax receivables
|
16
|
|
|
||
|
Other current assets and prepaid expenses
|
16
|
|
|
||
|
Current financial assets
|
13
|
|
|
||
|
Cash and cash equivalents
|
18
|
|
|
||
|
Assets held for sale
|
3
|
|
|
||
|
Total Current assets
|
|
|
|||
|
Total Assets
|
€
|
€
|
|||
|
Equity and liabilities
|
|||||
|
Equity
|
28
|
||||
|
Equity attributable to owners of the parent
|
|
|
|||
|
Non-controlling interests
|
|
|
|||
|
Total Equity
|
|
|
|||
|
Liabilities
|
|||||
|
Long-term debt
|
22
|
|
|
||
|
Other non-current financial liabilities
|
17
|
|
|
||
|
Other non-current liabilities
|
24
|
|
|
||
|
Non-current provisions
|
21
|
|
|
||
|
Employee benefits liabilities
|
20
|
|
|
||
|
Tax liabilities
|
|
|
|||
|
Deferred tax liabilities
|
7
|
|
|
||
|
Total Non-current liabilities
|
|
|
|||
|
Short-term debt and current portion of long-term debt
|
22
|
|
|
||
|
Current provisions
|
21
|
|
|
||
|
Employee benefit liabilities
|
20
|
|
|
||
|
Trade payables
|
23
|
|
|
||
|
Tax liabilities
|
|
|
|||
|
Other liabilities
|
24
|
|
|
||
|
Other current financial liabilities
|
17
|
|
|
||
|
Liabilities held for sale
|
3
|
|
|
||
|
Total Current liabilities
|
|
|
|||
|
Total Equity and liabilities
|
€
|
€
|
|||
|
Years ended December 31,
|
|||||||
|
Note
|
2024
|
2023
|
2022
|
||||
|
Net profit/(loss)
|
€
|
€
|
€
|
||||
|
Adjustments for non-cash items and other:
|
31
|
||||||
|
depreciation and amortization
|
|
|
|
||||
|
(gains)/losses on disposals
|
(
|
(
|
(
|
||||
|
change in deferred taxes
|
(
|
|
(
|
||||
|
other non-cash items
|
|
|
|
||||
|
Change in provisions and employee benefits liabilities
|
31
|
|
|
|
|||
|
Result of equity method investments net of dividends received
|
31
|
|
(
|
(
|
|||
|
Change in carrying amount of leased vehicles
|
(
|
(
|
(
|
||||
|
Changes in working capital
|
15
|
(
|
(
|
(
|
|||
|
Net cash from/(used in) operating activities
|
|
|
|
||||
|
Proceeds from disposal of shares in consolidated companies and of investments in
non-consolidated companies
|
|
|
|
||||
|
Acquisitions of consolidated subsidiaries and equity method and other investments
|
(
|
(
|
(
|
||||
|
Proceeds from disposals of property, plant and equipment and intangible assets
|
|
|
|
||||
|
Investments in property, plant and equipment and intangible assets
|
(
|
(
|
(
|
||||
|
Change in amounts payable on property, plant and equipment and intangible assets
|
|
|
(
|
||||
|
Net change in receivables from financing activities
|
(
|
(
|
(
|
||||
|
Other changes
|
|
(
|
(
|
||||
|
Net cash from/(used in) investing activities
|
(
|
(
|
(
|
||||
|
Distributions paid:
|
|||||||
|
to Stellantis shareholders
|
(
|
(
|
(
|
||||
|
to non-controlling shareholders of subsidiaries
|
(
|
|
(
|
||||
|
Proceeds from issuance of shares
|
|
|
|
||||
|
(Purchases)/sales of treasury shares
|
(
|
(
|
(
|
||||
|
Changes in short-term debt and other financial assets and liabilities
|
31
|
|
|
(
|
|||
|
Changes in long-term debt
|
31
|
|
(
|
(
|
|||
|
Change in securities
|
31
|
|
(
|
(
|
|||
|
Other changes
|
(
|
(
|
|
||||
|
Net cash from/(used in) financing activities
|
|
(
|
(
|
||||
|
Effect of changes in exchange rates
|
|
(
|
|
||||
|
(Increase)/decrease in cash and cash equivalents included in asset held for sale
|
(
|
(
|
(
|
||||
|
Increase/(decrease) in cash and cash equivalents
|
(
|
(
|
(
|
||||
|
Net cash and cash equivalents at beginning of the period
|
|
|
|
||||
|
Net cash and cash equivalents at end of the period
|
18
|
€
|
€
|
€
|
|||
|
Attributable to the Owners of the parent
|
||||||||||||||||||||||
|
Share
capital
(1)
|
Treasury
shares
|
Retained
earnings
and other
reserves
(1)
|
Cash flow
hedge
reserve
|
Remeasure
ment of the
fair value of
financial
assets
|
Actuarial
gains and
losses on
pension
obligations
plans
|
Effect of
change in
exchange
rates
|
Cumulative
share of
OCI of
equity
method
investees
|
Equity -
Attributa
ble to
Owners
of the
parent
|
Non-
controlling
interests
|
Total Equity
|
||||||||||||
|
At January 1, 2022
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
(
|
€
|
€
|
€
|
|||||||||||
|
Other comprehensive
income
|
—
|
—
|
—
|
(
|
|
|
|
(
|
|
|
|
|||||||||||
|
Net profit
|
—
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
(
|
|
|||||||||||
|
Total Other
comprehensive
income
|
—
|
—
|
|
(
|
|
|
|
(
|
|
(
|
|
|||||||||||
|
Capital increase
|
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|||||||||||
|
(Purchases) sales of
treasury shares
(1)
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
|||||||||||
|
Distributions
|
—
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||||
|
Share-based
compensation
|
—
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|||||||||||
|
Other changes
(2)
|
—
|
—
|
|
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||||
|
At December 31, 2022
|
|
(
|
|
(
|
|
|
|
(
|
|
|
|
|||||||||||
|
Other comprehensive
income
|
—
|
—
|
—
|
(
|
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||||||||
|
Net profit
|
—
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||||
|
Total Other
comprehensive
income
|
—
|
—
|
|
(
|
|
(
|
(
|
(
|
|
|
|
|||||||||||
|
(Purchases) sales of
treasury shares
(1)
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
|||||||||||
|
Cancellation of treasury
shares
|
(
|
|
(
|
—
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
|||||||||||
|
Distributions
|
—
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
(
|
|
(
|
|||||||||||
|
Share-based
compensation
|
—
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|||||||||||
|
Other changes
(2)
|
—
|
—
|
|
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||||
|
At December 31, 2023
|
|
(
|
|
(
|
|
|
|
(
|
|
|
|
|||||||||||
|
Other comprehensive
income
|
—
|
—
|
—
|
|
|
(
|
|
|
|
|
|
|||||||||||
|
Net profit
|
—
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||||
|
Total Other
comprehensive
income
|
—
|
—
|
|
|
|
(
|
|
|
|
|
|
|||||||||||
|
Issuance of special
voting shares
|
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|||||||||||
|
(Purchases) sales of
treasury shares
(1)
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
|||||||||||
|
Cancellation of treasury
shares
(1)
|
(
|
|
(
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|||||||||||
|
Distributions
|
—
|
—
|
(
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||||
|
Share-based
compensation
|
—
|
—
|
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|||||||||||
|
Other changes
(2)
|
—
|
—
|
|
(
|
—
|
—
|
—
|
—
|
|
(
|
|
|||||||||||
|
At December 31, 2024
|
€
|
€
(
|
€
|
€
(
|
€
|
€
|
€
|
€
(
|
€
|
€
|
€
|
|||||||||||
|
1.
|
Principal activities
|
|
2.
|
Basis of preparation
|
|
2024
|
2023
|
2022
|
|||||||||
|
Average
|
At December 31
|
Average
|
At December 31
|
Average
|
At December 31
|
||||||
|
U.S. Dollar (USD)
|
|
|
|
|
|
|
|||||
|
Canadian Dollar (CAD)
|
|
|
|
|
|
|
|||||
|
Mexican Peso (MXN)
|
|
|
|
|
|
|
|||||
|
Pound Sterling (GBP)
|
|
|
|
|
|
|
|||||
|
Polish Zloty (PLN)
|
|
|
|
|
|
|
|||||
|
Swiss Franc (CHF)
|
|
|
|
|
|
|
|||||
|
Turkish Lira (TRY)
(1)
|
n.a.
|
|
n.a.
|
|
n.a.
|
|
|||||
|
Brazilian Real (BRL)
|
|
|
|
|
|
|
|||||
|
Argentine Peso (ARS)
(2)
|
n.a.
|
|
n.a.
|
|
n.a.
|
|
|||||
|
Chinese Renminbi (CNY)
|
|
|
|
|
|
|
|||||
|
Japanese Yen (JPY)
|
|
|
|
|
|
|
|||||
|
Years
|
|
|
Buildings
|
|
|
Plant, machinery and equipment
|
|
|
Other assets - Assets subject to operating leases
|
|
|
Other assets - Other assets
|
|
|
Financial asset cash flow business model
|
Initial measurement
(1)
|
Measurement category
(3)
|
|
Solely to collect the contractual cash flows (Held to
Collect)
|
Fair Value including transaction costs
|
Amortized Cost
(2)
|
|
Collect both the contractual cash flows and generate
cash flows arising from the sale of assets (Held to
Collect and Sell)
|
Fair Value including transaction costs
|
Fair value through other comprehensive
income (“FVOCI”)
|
|
Generate cash flows primarily from the sale of
assets (Held to Sell)
|
Fair Value
|
FVPL
|
|
Financial asset
|
IFRS 9 impairment model
|
|
Trade receivables
|
Simplified approach
|
|
Receivables from financing activities
|
General approach
|
|
Other receivables
|
General approach
|
|
Stage
|
Description
|
Time period for
measurement of ECL
|
|
Stage 1
|
A financial instrument that is not credit-impaired on initial recognition
|
12-month ECL
|
|
Stage 2
|
A financial instrument with a significant increase in credit risk since initial
recognition
|
Lifetime ECL
|
|
Stage 3
|
A financial instrument that is credit-impaired or has defaulted
|
Lifetime ECL
|
|
Effect on
pension
benefit
obligation
increase/
(decrease) in
Net liability
|
Germany and
France
|
UK
|
U.S. and
Canada
|
Other
|
|||||
|
(€ million)
|
|||||||||
|
|
|
|
|
|
|
||||
|
|
(
|
(
|
(
|
(
|
(
|
||||
|
Effect on health
care, life insurance and OPEB
obligation
|
|
|
(€ million)
|
|
|
|
|
|
|
(
|
|
|
(
|
|
|
|
|
3.
|
Scope of consolidation
|
|
Name
|
Country
|
Percentage
Interest Held
|
||
|
North America
|
||||
|
FCA US LLC
|
USA
|
|
||
|
FCA Canada Inc.
|
Canada
|
|
||
|
Stellantis Mexico, S.A. de C.V.
|
Mexico
|
|
|
South America
|
||||
|
Stellantis Automoveis Brasil Ltda.
|
Brazil
|
|
||
|
FCA Automobiles Argentina S.A.
|
Argentina
|
|
||
|
Peugeot Citroën Argentina S.A.
|
Argentina
|
|
||
|
Enlarged Europe
|
||||
|
Stellantis Europe S.p.A.
|
Italy
|
|
||
|
Automobiles Peugeot
|
France
|
|
||
|
Automobiles Citroën
|
France
|
|
||
|
Opel Automobile GmbH
|
Germany
|
|
||
|
Groupe PSA Italia S.p.A.
|
Italy
|
|
||
|
Stellantis & You France S.A.S.
|
France
|
|
||
|
Stellantis Auto S.A.S.
|
France
|
|
||
|
FCA Germany GmbH
|
Germany
|
|
||
|
Stellantis España, S.L.
|
Spain
|
|
||
|
Vauxhall Motors Limited
|
United Kingdom
|
|
||
|
FCA France S.A.S.
|
France
|
|
||
|
Peugeot Motor Company PLC
|
United Kingdom
|
|
||
|
Stellantis & You UK Limited
|
United Kingdom
|
|
||
|
Peugeot Deutschland GmbH
|
Germany
|
|
||
|
Stellantis & You Italia S.p.A.
|
Italy
|
|
||
|
Stellantis Nederland B.V.
|
Netherlands
|
|
||
|
Citroën Deutschland GmbH
|
Germany
|
|
||
|
Citroën UK Ltd
|
United Kingdom
|
|
||
|
FCA Poland S.p.z.o.o.
|
Poland
|
|
||
|
Stellantis Belux S.A.
|
Belgium
|
|
||
|
Middle East & Africa
|
||||
|
Stellantis Middle East FZE
|
United Arab Emirates
|
|
||
|
Stellantis Otomotiv Pazarlama Anonim Sirketi
|
Turkey
|
|
||
|
China and India & Asia Pacific
|
||||
|
Stellantis Japan Ltd.
|
Japan
|
|
||
|
Fiat India Automobiles Private Limited
|
India
|
|
||
|
Maserati
|
||||
|
Maserati S.p.A.
|
Italy
|
|
||
|
Maserati (China) Cars Trading Co., Ltd.
|
People's Rep.of China
|
|
||
|
Maserati North America Inc.
|
USA
|
|
||
|
Financial Services
|
||||
|
Stellantis Financial Services Europe
|
France
|
|
||
|
Stellantis Automotive Finance Co. Ltd.
|
People's Rep.of China
|
|
||
|
Stellantis Financial Services US Corp.
|
USA
|
|
||
|
Banco Stellantis S.A.
|
Brazil
|
|
||
|
Fidis S.p.A.
|
Italy
|
|
||
|
Holdings & Other Companies
|
||||
|
FCA North America Holdings LLC
|
USA
|
|
||
|
GIE PSA Trésorerie
|
France
|
|
||
|
Fiat Chrysler Finance North America, Inc.
|
USA
|
|
||
|
FCA US Insurance Company
|
USA
|
|
|
Fiat Chrysler Finance S.p.A.
|
Italy
|
|
||
|
Stellantis International S.A.
|
Switzerland
|
|
|
4.
|
Net revenues
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Revenues from:
|
|||||
|
Shipments of vehicles and sales of other goods
|
€
|
€
|
€
|
||
|
Other services provided
|
|
|
|
||
|
Construction contract revenues
|
|
|
|
||
|
Lease installments from assets sold with a buy-back commitment
|
|
|
|
||
|
Interest income of financial services activities
|
|
|
|
||
|
Total Net revenues
|
€
|
€
|
€
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Net revenues in:
|
|||||
|
North America
(1)
|
€
|
€
|
€
|
||
|
France
|
|
|
|
||
|
Brazil
|
|
|
|
||
|
Italy
|
|
|
|
||
|
Germany
|
|
|
|
||
|
United Kingdom
|
|
|
|
||
|
Turkey
|
|
|
|
||
|
Spain
|
|
|
|
||
|
Belgium
|
|
|
|
||
|
Netherlands
|
|
|
|
||
|
Argentina
|
|
|
|
||
|
Portugal
|
|
|
|
||
|
Algeria
|
|
|
|
||
|
Poland
|
|
|
|
||
|
Austria
|
|
|
|
||
|
Japan
|
|
|
|
||
|
Switzerland
|
|
|
|
||
|
China
|
|
|
|
||
|
Other countries
|
|
|
|
||
|
Total Net revenues
|
€
|
€
|
€
|
||
|
2024
|
North
America
|
Enlarged
Europe
|
Middle
East &
Africa
|
South
America
|
China
and India
& Asia
Pacific
|
Maserati
|
Other
activities
|
Total
|
||||||||
|
(€ million)
|
||||||||||||||||
|
Revenues from:
|
||||||||||||||||
|
Shipments of vehicles and sales of other
goods
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
Other services provided
|
|
|
|
|
|
|
|
|
||||||||
|
Construction contract revenues
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues from goods and services
|
|
|
|
|
|
|
|
|
||||||||
|
Lease installments from assets sold with a
buy-back commitment
|
|
|
|
|
|
|
|
|
||||||||
|
Interest income from financial services
activities
|
|
|
|
|
|
|
|
|
||||||||
|
Total Net revenues
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
2023
|
North
America
|
Enlarged
Europe
|
Middle
East &
Africa
|
South
America
|
China
and India
& Asia
Pacific
|
Maserati
|
Other
activities
|
Total
|
||||||||
|
(€ million)
|
||||||||||||||||
|
Revenues from:
|
||||||||||||||||
|
Shipments of vehicles and sales of other
goods
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
Other services provided
|
|
|
|
|
|
|
|
|
||||||||
|
Construction contract revenues
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues from goods and services
|
|
|
|
|
|
|
|
|
||||||||
|
Lease installments from assets sold with a buy-
back commitment
|
|
|
|
|
|
|
|
|
||||||||
|
Interest income from financial services
activities
|
|
|
|
|
|
|
|
|
||||||||
|
Total Net revenues
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
2022
|
North
America
|
Enlarged
Europe
|
Middle
East &
Africa
|
South
America
|
China
and India
& Asia
Pacific
|
Maserati
|
Other
activities
|
Total
|
||||||||
|
(€ million)
|
||||||||||||||||
|
Revenues from:
|
||||||||||||||||
|
Shipments of vehicles and sales of other
goods
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
Other services provided
|
|
|
|
|
|
|
|
|
||||||||
|
Construction contract revenues
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues from goods and services
|
|
|
|
|
|
|
|
|
||||||||
|
Lease installments from assets sold with a
buy-back commitment
|
|
|
|
|
|
|
|
|
||||||||
|
Interest income from financial services
activities
|
|
|
|
|
|
|
|
|
||||||||
|
Total Net revenues
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
5.
|
Research and development costs
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Research and development expenditures expensed
|
€
|
€
|
€
|
||
|
Amortization of capitalized development expenditures
|
|
|
|
||
|
Impairment and write-off of capitalized development expenditures
|
|
|
|
||
|
Total Research and development costs
|
€
|
€
|
€
|
||
|
6.
|
Net financial expenses/(income)
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Interest income and other financial income
|
€
|
€
|
€
|
||
|
Financial expenses:
|
|||||
|
Interest expense and other financial expenses:
|
|
|
|
||
|
Interest expense on notes
|
|
|
|
||
|
Interest expense on borrowings from bank
|
|
|
|
||
|
Other interest cost and financial expenses
|
|
|
|
||
|
Interest on lease liabilities
|
|
|
|
||
|
Write-down and reversals of write-downs of financial assets
|
(
|
|
|
||
|
Net interest expense/(income) on employee benefits provisions
|
|
|
|
||
|
Total Financial expenses
|
|
|
|
||
|
Net expenses from derivative financial instruments and exchange rate differences
|
|
|
|
||
|
Total Financial expenses and Net expenses from derivative financial
instruments and exchange rate differences
|
|
|
|
||
|
Net Financial expenses/(income)
|
€
(
|
€
(
|
€
|
||
|
7.
|
Tax expense/(benefit)
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Current tax expense
|
€
|
€
|
€
|
||
|
Deferred tax expense/(benefit)
|
(
|
|
(
|
||
|
Tax expense/(benefit) relating to prior periods
(1)
|
(
|
(
|
|
||
|
Total Tax expense/(benefit)
|
€
(
|
€
|
€
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Profit/(loss) before tax
|
€
|
€
|
€
|
||
|
Income tax rate
|
|
|
|
||
|
Theoretical income taxes
|
€
|
€
|
€
|
||
|
Tax effect on:
|
|||||
|
Differences between foreign tax rates and the theoretical applicable tax rate and
tax holidays
|
|
(
|
(
|
||
|
Recognition and utilization of previously unrecognized deferred tax assets
|
(
|
(
|
(
|
||
|
Deferred tax assets not recognized and write-downs
|
|
|
|
||
|
Permanent differences
|
(
|
(
|
(
|
||
|
Tax credits
|
(
|
(
|
(
|
||
|
Withholding tax
|
|
|
|
||
|
Other differences
|
|
(
|
(
|
||
|
Total Tax expense/(benefit)
|
€
(
|
€
|
€
|
||
|
Effective tax rate
|
-
|
|
|
||
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Deferred tax assets
(1)
|
€
|
€
|
|
|
Deferred tax liabilities
(1)
|
(
|
(
|
|
|
Total Net deferred tax assets/(liabilities)
|
€
(
|
€
(
|
|
|
At January 1,
2024
|
Recognized in
Consolidated
Income
Statement
|
Recognized in
Equity
|
Transferred
to Assets/
(Liabilities)
Held for Sale
|
Translation
differences and
Other
|
At December
31, 2024
|
||||||
|
(€ million)
|
|||||||||||
|
Deferred tax liabilities arising on:
|
|||||||||||
|
Accelerated depreciation
|
€
(
|
€
(
|
€
|
€
|
€
(
|
€
(
|
|||||
|
Capitalized development assets
|
(
|
|
|
|
|
(
|
|||||
|
Other Intangible assets and
Intangible assets with indefinite
useful lives
|
(
|
|
|
|
(
|
(
|
|||||
|
Right-of-use assets
|
(
|
(
|
|
|
(
|
(
|
|||||
|
Provision for employee benefits
|
(
|
(
|
|
|
(
|
(
|
|||||
|
Other
|
(
|
(
|
(
|
|
(
|
(
|
|||||
|
Total deferred tax liabilities
|
€
(
|
€
|
€
|
€
|
€
(
|
€
(
|
|||||
|
Deferred tax assets arising on:
|
|||||||||||
|
Provisions
|
|
|
|
|
(
|
|
|||||
|
Provision for employee benefits
|
|
|
(
|
|
|
|
|||||
|
Lease liabilities
|
|
|
|
|
|
|
|||||
|
Impairment of tangible and
intangible assets
|
|
(
|
|
|
(
|
|
|||||
|
Inventories
|
|
(
|
|
|
(
|
|
|||||
|
Allowances for doubtful
accounts
|
|
|
|
|
(
|
|
|||||
|
Provision for buy back
|
|
(
|
|
|
|
|
|||||
|
Other
|
|
(
|
(
|
|
(
|
|
|||||
|
Total deferred tax assets
|
€
|
€
|
€
(
|
€
|
€
|
€
|
|||||
|
Unrecognized deferred tax assets
on temporary differences
(1)
|
(
|
|
|
|
|
(
|
|||||
|
Deferred tax assets arising on tax
loss carry-forwards
|
|
|
|
|
(
|
|
|||||
|
Unrecognized deferred tax assets
on tax loss carry-forwards
|
(
|
|
|
|
|
(
|
|||||
|
Total Net deferred tax assets/
(liabilities)
|
€
(
|
€
|
€
(
|
€
|
€
(
|
€
(
|
|||||
|
At January 1,
2023
|
Recognized in
Consolidated
Income
Statement
|
Recognized in
Equity
|
Transferred
to Assets/
(Liabilities)
Held for Sale
|
Translation
differences
and Other
|
At December
31, 2023
|
||||||
|
(€ million)
|
|||||||||||
|
Deferred tax liabilities arising on:
|
|||||||||||
|
Accelerated depreciation
|
€
(
|
€
(
|
€
|
€
|
€
(
|
€
(
|
|||||
|
Capitalized development assets
|
(
|
|
|
|
|
(
|
|||||
|
Other Intangible assets and
Intangible assets with indefinite
useful lives
|
(
|
(
|
|
|
|
(
|
|||||
|
Right-of-use assets
|
(
|
|
|
|
|
(
|
|||||
|
Provision for employee benefits
|
(
|
(
|
(
|
|
|
(
|
|||||
|
Other
|
(
|
|
|
(
|
|
(
|
|||||
|
Total deferred tax liabilities
|
€
(
|
€
|
€
|
€
(
|
€
|
€
(
|
|||||
|
Deferred tax assets arising on:
|
|||||||||||
|
Provisions
|
|
(
|
(
|
|
(
|
|
|||||
|
Provision for employee benefits
|
|
(
|
|
|
(
|
|
|||||
|
Lease liabilities
|
|
(
|
|
|
(
|
|
|||||
|
Impairment of tangible and
intangible assets
|
|
(
|
(
|
|
(
|
|
|||||
|
Inventories
|
|
|
|
|
|
|
|||||
|
Allowances for doubtful
accounts
|
|
|
(
|
|
(
|
|
|||||
|
Provision for buy back
|
|
|
|
|
(
|
|
|||||
|
Other
|
|
(
|
|
|
|
|
|||||
|
Total deferred tax assets
|
€
|
€
(
|
€
|
€
|
€
|
€
|
|||||
|
Unrecognized deferred tax assets
on temporary differences
(1)
|
(
|
|
|
|
(
|
(
|
|||||
|
Deferred tax assets arising on tax
loss carry-forwards
|
|
(
|
|
|
(
|
|
|||||
|
Unrecognized deferred tax assets
on tax loss carry-forwards
|
(
|
|
|
|
(
|
(
|
|||||
|
Total Net deferred tax assets /
(liabilities)
|
€
(
|
€
(
|
€
|
€
(
|
€
|
€
(
|
|||||
|
Tax loss carry-forward
(after application of the
current tax rate)
|
Recognized deferred tax
assets on tax loss carry-
forward
|
Unrecognized deferred tax
assets on tax loss carry-
forwards (after application
of the current tax rate)
|
||||
|
At December 31, 2024
|
||||||
|
(€ million)
|
||||||
|
Tax Groups:
|
||||||
|
France
|
€
|
€
(
|
€
|
|||
|
Germany
|
|
(
|
|
|||
|
Spain
|
|
(
|
|
|||
|
Italy
|
|
(
|
|
|||
|
Other Jurisdictions:
|
||||||
|
Brazil
|
|
(
|
|
|||
|
Others
|
|
(
|
|
|||
|
Total
|
€
|
€
(
|
€
|
|||
|
Tax loss carry-forward
(after application of the
current tax rate)
|
Recognized deferred tax
assets on tax loss carry-
forward
|
Unrecognized deferred tax
assets on tax loss carry-
forwards (after application
of the current tax rate)
|
||||
|
At December 31, 2023
|
||||||
|
(€ million)
|
||||||
|
Tax Groups:
|
||||||
|
France
|
€
|
€
(
|
€
|
|||
|
Germany
|
|
(
|
|
|||
|
Spain
|
|
(
|
|
|||
|
Italy
|
|
(
|
|
|||
|
Other Jurisdictions:
|
||||||
|
Brazil
|
|
|
|
|||
|
Others
|
|
(
|
|
|||
|
Total
|
€
|
€
(
|
€
|
|||
|
8.
|
Other information by nature
|
|
Years ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
(€ million)
|
||||||
|
Depreciation of right-of-use assets
|
€
|
€
|
€
|
|||
|
Interest expense on lease liabilities
|
|
|
|
|||
|
Variable lease payments not included in the
measurement of lease liabilities
|
|
|
|
|||
|
Income from sub-leasing right-of-use assets
|
(
|
(
|
(
|
|||
|
Expenses relating to short-term leases and to leases
of low-value assets
|
|
|
|
|||
|
Gains arising from sale and leaseback transactions
|
(
|
(
|
(
|
|||
|
Total expense recognized in Net profit
|
€
|
€
|
€
|
|||
|
9.
|
Goodwill and intangible assets with indefinite useful lives
|
|
Goodwill
|
||||||||||||
|
Gross amount
|
Accumulated
impairment
losses
|
Total
Goodwill
|
Brands
|
Other
|
Total
Goodwill and
intangible
assets with
indefinite
useful lives
|
|||||||
|
(€ million)
|
||||||||||||
|
At January 1, 2023
|
€
|
€
(
|
€
|
€
|
€
|
€
|
||||||
|
Additions
|
|
|
|
|
|
|
||||||
|
Disposal
|
(
|
|
(
|
|
|
(
|
||||||
|
Translation differences and
other
|
(
|
|
(
|
(
|
|
(
|
||||||
|
At December 31, 2023
|
|
(
|
|
|
|
|
||||||
|
Additions
(1)
|
|
|
|
|
|
|
||||||
|
Impairment losses and assets
write-offs
2)
|
|
(
|
(
|
|
|
(
|
||||||
|
Translation differences and
other
|
|
|
|
|
(
|
|
||||||
|
At December 31, 2024
|
€
|
€
(
|
€
|
€
|
€
|
€
|
||||||
|
At December 31, 2024
|
At December 31, 2023
|
|||||||
|
(€ million)
|
Goodwill
|
Brands
|
Goodwill
|
Brands
|
||||
|
North America
|
€
|
€
|
€
|
€
|
||||
|
Enlarged Europe
|
|
|
|
|
||||
|
Middle East & Africa
|
|
|
|
|
||||
|
South America
|
|
|
|
|
||||
|
China and India & Asia Pacific
|
|
|
|
|
||||
|
Maserati
|
|
|
|
|
||||
|
Other activities
|
|
|
|
|
||||
|
Total
|
€
|
€
|
€
|
€
|
||||
|
10.
|
Other intangible assets
|
|
Capitalized
development
expenditures
|
Patents,
concessions
and licenses
|
Other
intangible
assets
|
Total
|
||||
|
(€ million)
|
|||||||
|
Gross carrying amount at January 1, 2023
|
€
|
€
|
€
|
€
|
|||
|
Additions
|
|
|
|
|
|||
|
Divestitures
|
(
|
(
|
(
|
(
|
|||
|
Change in scope of consolidation
|
|
|
|
|
|||
|
Translation differences and other changes
|
(
|
|
(
|
(
|
|||
|
At December 31, 2023
|
|
|
|
|
|||
|
Additions
|
|
|
|
|
|||
|
Divestitures
|
(
|
(
|
(
|
(
|
|||
|
Change in scope of consolidation
|
|
(
|
|
|
|||
|
Transfer to Assets held for sale
|
|
|
(
|
(
|
|||
|
Translation differences and other changes
|
|
|
|
|
|||
|
At December 31, 2024
|
|
|
|
|
|||
|
Accumulated amortization and impairment losses at
January 1, 2023
|
|
|
|
|
|||
|
Amortization
|
|
|
|
|
|||
|
Impairment losses and asset write-offs
|
|
|
|
|
|||
|
Divestitures
|
(
|
(
|
(
|
(
|
|||
|
Change in scope of consolidation
|
|
|
|
|
|||
|
Translation differences and other changes
|
(
|
(
|
(
|
(
|
|||
|
At December 31, 2023
|
|
|
|
|
|||
|
Amortization
|
|
|
|
|
|||
|
Impairment losses, reversals and asset write-offs
|
|
|
|
|
|||
|
Divestitures
|
(
|
(
|
(
|
(
|
|||
|
Change in scope of consolidation
|
(
|
|
|
(
|
|||
|
Translation differences and other changes
|
|
|
|
|
|||
|
At December 31, 2024
|
|
|
|
|
|||
|
Carrying amount at December 31, 2023
|
€
|
€
|
€
|
€
|
|||
|
Carrying amount at December 31, 2024
|
€
|
€
|
€
|
€
|
|||
|
11.
|
Property, plant and equipment
|
|
Land
|
Buildings
|
Plant, machinery
and equipment
|
Other
assets
|
Advances and
tangible assets
in progress
|
Total
|
||||||
|
(€ million)
|
|||||||||||
|
Gross carrying amount at January 1, 2023
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Additions
|
|
|
|
|
|
|
|||||
|
Divestitures and disposals
|
(
|
(
|
(
|
(
|
|
(
|
|||||
|
Change in the scope of consolidation
|
(
|
|
|
(
|
|
|
|||||
|
Translation differences
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Transfer to Assets held for sale
|
(
|
(
|
(
|
|
|
(
|
|||||
|
Other changes
|
(
|
|
|
|
(
|
(
|
|||||
|
At December 31, 2023
|
|
|
|
|
|
|
|||||
|
Additions
|
|
|
|
|
|
|
|||||
|
Divestitures and disposals
|
(
|
(
|
(
|
(
|
|
(
|
|||||
|
Change in the scope of consolidation
|
|
|
(
|
|
|
|
|||||
|
Translation differences
|
|
|
|
|
|
|
|||||
|
Transfer to Assets held for sale
|
(
|
(
|
(
|
(
|
|
(
|
|||||
|
Other changes
|
(
|
|
|
(
|
(
|
(
|
|||||
|
At December 31, 2024
|
|
|
|
|
|
|
|||||
|
Accumulated depreciation and impairment
losses at January 1, 2023
|
|
|
|
|
|
|
|||||
|
Depreciation
|
|
|
|
|
|
|
|||||
|
Divestitures and disposal
|
(
|
(
|
(
|
(
|
|
(
|
|||||
|
Impairment losses and asset write-offs
|
|
(
|
|
|
|
|
|||||
|
Change in the scope of consolidation
|
|
|
|
|
|
|
|||||
|
Translation differences
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Transfer to Assets held for sale
|
|
(
|
(
|
|
|
(
|
|||||
|
Other changes
|
(
|
|
|
|
(
|
|
|||||
|
At December 31, 2023
|
|
|
|
|
|
|
|||||
|
Depreciation
|
|
|
|
|
|
|
|||||
|
Divestitures and disposals
|
(
|
(
|
(
|
(
|
|
(
|
|||||
|
Impairment losses and asset write-offs
|
|
|
|
|
|
|
|||||
|
Change in the scope of consolidation
|
|
|
(
|
|
|
(
|
|||||
|
Translation differences
|
|
|
|
|
(
|
|
|||||
|
Transfer to Assets held for sale
|
|
(
|
(
|
(
|
|
(
|
|||||
|
Other changes
|
(
|
|
(
|
(
|
(
|
(
|
|||||
|
At December 31, 2024
|
|
|
|
|
|
|
|||||
|
Carrying amount at December 31, 2023
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Carrying amount at December 31, 2024
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Assets subject to
operating leases
|
Other assets
|
Total
|
|||
|
(€ million)
|
|||||
|
Gross carrying amount at January 1, 2023
|
€
|
€
|
€
|
||
|
Additions
|
|
|
|
||
|
Divestitures and disposals
|
(
|
(
|
(
|
||
|
Translation differences
|
(
|
(
|
(
|
||
|
Change in scope
|
|
(
|
(
|
||
|
Other changes
|
|
|
|
||
|
At December 31, 2023
|
|
|
|
||
|
Additions
|
|
|
|
||
|
Divestitures and disposals
|
(
|
(
|
(
|
||
|
Transfer to Assets held for sale
|
|
(
|
(
|
||
|
Translation differences
|
|
|
|
||
|
Change in scope
|
|
|
|
||
|
Other changes
|
(
|
|
(
|
||
|
At December 31, 2024
|
|
|
|
||
|
Accumulated depreciation and impairment losses at January 1, 2023
|
|
|
|
||
|
Depreciation
|
|
|
|
||
|
Impairment losses and asset write offs
|
|
|
|
||
|
Divestitures
|
(
|
(
|
(
|
||
|
Translation differences
|
|
(
|
(
|
||
|
Other changes
|
|
|
|
||
|
At December 31, 2023
|
|
|
|
||
|
Depreciation
|
|
|
|
||
|
Divestitures
|
(
|
(
|
(
|
||
|
Transfer to Assets held for sale
|
|
(
|
(
|
||
|
Translation differences
|
|
|
|
||
|
Change in scope
|
|
|
|
||
|
Other changes
|
(
|
(
|
(
|
||
|
At December 31, 2024
|
|
|
|
||
|
Carrying amount at December 31, 2023
|
€
|
€
|
€
|
||
|
Carrying amount at December 31, 2024
|
€
|
€
|
€
|
||
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Within one year
|
€
|
€
|
|
|
Between one and two years
|
|
|
|
|
Between two and three years
|
|
|
|
|
Between three and four years
|
|
|
|
|
Between four and five years
|
|
|
|
|
Later than five years
|
|
|
|
|
Total undiscounted lease payments to be received
|
€
|
€
|
|
|
Land
|
Buildings
|
Plant,
machinery and
equipment
|
Other assets
|
Total
|
||||||
|
(€ million)
|
||||||||||
|
Balance at January 1, 2023
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Depreciation
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Additions
|
|
|
|
|
|
|||||
|
Divestitures
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Change in the scope of consolidation
|
|
|
|
|
|
|||||
|
Translation differences
|
|
(
|
(
|
(
|
(
|
|||||
|
Other
|
|
|
(
|
|
|
|||||
|
Balance at December 31, 2023
|
|
|
|
|
|
|||||
|
Depreciation
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Additions
|
|
|
|
|
|
|||||
|
Divestitures
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Change in the scope of consolidation
|
|
|
|
|
|
|||||
|
Translation differences
|
|
|
|
|
|
|||||
|
Other
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Balance at December 31, 2024
|
€
|
€
|
€
|
€
|
€
|
|||||
|
12.
|
Investments accounted for using the equity method
|
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Joint ventures
|
€
|
€
|
|
|
Associates
|
|
|
|
|
Other
|
|
|
|
|
Total Investments accounted for using the equity method
|
€
|
€
|
|
|
Ownership percentage
|
Investment balance
|
|||||||
|
At December 31,
|
At December 31,
|
|||||||
|
2024
|
2023
|
2024
|
2023
|
|||||
|
Ownership percentage
|
(€ million)
|
|||||||
|
Finance companies in partnership with Group Santander Consumer
Finance (“SCF”)
|
|
|
€
|
€
|
||||
|
Finance companies in partnership with BNPP PF
|
|
|
|
|
||||
|
Tofas-Turk Otomobil Fabrikasi A.S.
|
|
|
|
|
||||
|
NextStar Energy Inc (“NextStar”)
|
|
|
|
|
||||
|
StarPlus Energy LLC (“StarPlus”)
|
|
|
|
|
||||
|
Automotive Cells Company SE (“ACC”)
|
|
|
|
|
||||
|
Leasys SAS
|
|
|
|
|
||||
|
Symbio
|
|
|
|
|
||||
|
Others
|
|
|
||||||
|
Total joint ventures
|
€
|
€
|
||||||
|
Zhejiang Leapmotor Technology Co., Ltd. (“Leapmotor”)
|
|
|
|
|
||||
|
Archer Aviation Inc (“Archer”)
|
|
|
|
|
||||
|
Nordex S.A.
|
|
|
|
|
||||
|
360 Energy S.A.
|
|
|
|
|
||||
|
Stellantis E-Transmission N.V.
(1)
|
|
|
|
|
||||
|
Comau Group S.p.A
.(1)
|
|
|
|
|
||||
|
Others
|
|
|
||||||
|
Total associates
|
€
|
€
|
||||||
|
Total joint ventures and associates
|
€
|
€
|
||||||
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Financial assets
|
€
|
€
|
|
|
Of which: Cash and cash equivalents
|
|
|
|
|
Other assets
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Other liabilities
|
|
|
|
|
Total Equity
|
|
|
|
|
Carrying amount of interest
|
|||
|
Company’s share of net assets
|
|
|
|
|
Carrying amount of interest
|
€
|
€
|
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Interest and similar income
|
€
|
€
|
€
|
||
|
Interest and similar expenses
|
(
|
(
|
(
|
||
|
Income tax expense
|
(
|
(
|
(
|
||
|
Profit from continuing operations
|
|
|
|
||
|
Net profit
|
|
|
|
||
|
Net profit attributable to owners of the parent (A)
|
|
|
|
||
|
Other comprehensive income/(loss) attributable to owners of the parent (B)
|
|
|
(
|
||
|
Total Comprehensive income attributable to owners of the parent (A+B)
|
€
|
€
|
€
|
||
|
Company’s share of net profit
|
€
|
€
|
€
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Joint ventures
|
€
|
€
|
€
|
||
|
Associates
|
(
|
(
|
|
||
|
Other
|
(
|
(
|
(
|
||
|
Total Share of the profit/(loss) of equity method investees
|
€
(
|
€
|
€
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Joint ventures:
|
|||||
|
Profit/(loss) from continuing operations
|
€
(
|
€
|
€
(
|
||
|
Net profit/(loss)
|
(
|
|
(
|
||
|
Other comprehensive income/(loss)
|
(
|
(
|
(
|
||
|
Total Other comprehensive income/(loss)
|
€
(
|
€
(
|
€
(
|
||
|
Associates:
|
|||||
|
Profit/(loss) from continuing operations
|
€
(
|
€
(
|
€
|
||
|
Net profit/(loss)
|
(
|
(
|
|
||
|
Other comprehensive income /(loss)
|
|
(
|
|
||
|
Total Other comprehensive income/(loss)
|
€
(
|
€
(
|
€
|
||
|
13.
|
Financial assets
|
|
At December 31,
|
|||||||||||||
|
2024
|
2023
|
||||||||||||
|
Note
|
Current
|
Non-
current
|
Total
|
Current
|
Non-
current
|
Total
|
|||||||
|
(€ million)
|
|||||||||||||
|
Derivative financial assets
|
17
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
Financial securities measured at fair value through
other comprehensive income
|
25
|
|
|
|
|
|
|
||||||
|
Financial securities measured at fair value through
profit or loss
|
25
|
|
|
|
|
|
|
||||||
|
Financial securities measured at amortized cost
|
|
|
|
|
|
|
|||||||
|
Financial receivables
(1)
|
25
|
|
|
|
|
|
|
||||||
|
Collateral deposits measured at fair value through
profit or loss
(2)
|
25
|
|
|
|
|
|
|
||||||
|
Total financial assets
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||
|
14.
|
Inventories
|
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Finished goods and goods for resale
|
€
|
€
|
|
|
Work-in-progress, raw materials and manufacturing supplies
|
|
|
|
|
Amount due from customers for contract work
|
|
|
|
|
Total Inventories
|
€
|
€
|
|
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Aggregate amount of costs incurred and recognized profits (less recognized losses) to date
|
€
|
€
|
|
|
Less: Progress billings
|
|
|
|
|
Construction contracts, net asset/(liability)
|
€
|
€
|
|
|
Construction contract assets
|
|
|
|
|
Less: Construction contract liabilities (Note 24)
|
|
|
|
|
Construction contracts, net asset/(liability)
|
€
|
€
|
|
|
At January 1,
2024
|
Advances
received from
customers
|
Amounts
recognized
within revenue
|
Disposal
|
At December
31, 2024
|
||||||
|
(€ million)
|
||||||||||
|
Construction contracts, net asset/(liability)
|
€
|
€
(
|
€
|
€
(
|
€
|
|||||
|
15.
|
Working capital
|
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
(Increase)/decrease in inventories
|
€
|
€
(
|
€
(
|
||
|
(Increase)/decrease in trade receivables
|
|
(
|
(
|
||
|
Increase/(decrease) in trade payables
|
(
|
|
|
||
|
Other changes
|
(
|
|
(
|
||
|
Total change in working capital
|
€
(
|
€
(
|
€
(
|
||
|
16.
|
Trade receivables, other assets, prepaid expenses and tax receivables
|
|
At January 1,
2024
|
Provision
|
Use and
other changes
|
Transferred to
Assets held for
sale
|
At December
31, 2024
|
|||||
|
(€ million)
|
|||||||||
|
ECL allowance - Trade receivables
|
€
|
€
|
€
(
|
€
|
€
|
||||
|
At December 31,
|
||||||||||||
|
2024
|
2023
|
|||||||||||
|
Current and
less than 90
days past
due
|
90 days or
more past
due
|
Total
|
Current and
less than 90
days past
due
|
90 days or
more past
due
|
Total
|
|||||||
|
(€ million)
|
||||||||||||
|
Gross amount
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
ECL allowance
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||
|
Carrying amount
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Dealer financing
|
€
|
€
|
|
|
Retail financing
|
|
|
|
|
Finance leases
|
|
|
|
|
Other
|
|
|
|
|
Total Receivables from financing activities
|
€
|
€
|
|
|
At January 1,
2024
|
Provision
|
Use and
other changes
|
Transferred to
Assets held for
sale
|
At December
31, 2024
|
|||||
|
(€ million)
|
|||||||||
|
ECL allowance - Receivables from financing
activities
|
€
|
€
|
€
(
|
€
(
|
€
|
||||
|
At December 31,
|
||||||||||||||||
|
2024
|
2023
|
|||||||||||||||
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|||||||||
|
(€ million)
|
||||||||||||||||
|
Gross amount
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
ECL allowance
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||
|
Carrying amount
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
At December 31
|
|||||||||||
|
2024
|
2023
|
||||||||||
|
Current
|
Non-current
|
Total
|
Current
|
Non-current
|
Total
|
||||||
|
(€ million)
|
|||||||||||
|
Receivables from financing activities at
amortized cost
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Other receivables at amortized cost
|
|
|
|
|
|
|
|||||
|
Defined benefit plan assets (Note 20)
|
|
|
|
|
|
|
|||||
|
Derivative operating assets
|
|
|
|
|
|
|
|||||
|
Prepaid expenses and other
|
|
|
|
|
|
|
|||||
|
Total other assets and prepaid expenses
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
At December 31,
|
|||||||||||||||||||
|
2024
|
2023
|
||||||||||||||||||
|
Total
due within
one year
(current)
|
Due
between
one and
five years
|
Due
beyond
five years
|
Total due
after one
year
(non-
current)
|
Total
|
Total
due within
one year
(current)
|
Due
between
one and
five years
|
Due
beyond
five years
|
Total due
after one
year
(non-
current)
|
Total
|
||||||||||
|
(€ million)
|
|||||||||||||||||||
|
Receivables from
financing activities
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Other receivables at
amortized cost
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Derivative operating
assets
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Total
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Tax receivables
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
At December 31,
|
|||||||||||
|
2024
|
2023
|
||||||||||
|
Trade
receivables
|
Receivables
from
financing
activities
|
Total
|
Trade
receivables
|
Receivables
from
financing
activities
|
Total
|
||||||
|
(€ million)
|
|||||||||||
|
Carrying amount of assets transferred and not
derecognized
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Carrying amount of the related liabilities (Note 22)
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
17.
|
Derivative financial and operating assets and liabilities
|
|
At December 31,
|
|||||||
|
2024
|
2023
|
||||||
|
Positive fair
value
|
Negative fair
value
|
Positive fair
value
|
Negative fair
value
|
||||
|
(€ million)
|
|||||||
|
Fair value hedges:
|
|||||||
|
Interest rate risk - interest rate swaps
|
€
|
€
|
€
|
€
(
|
|||
|
Total Fair value hedges
|
|
|
|
(
|
|||
|
Cash flow hedges:
|
|||||||
|
Interest rate risk - interest rate swaps
|
|
(
|
|
(
|
|||
|
Currency risks - forward contracts, currency swaps and
currency options
|
|
(
|
|
(
|
|||
|
Commodity price risk – commodity swaps and commodity
options
|
|
(
|
|
(
|
|||
|
Total Cash flow hedges
|
|
(
|
|
(
|
|||
|
Total Net investment hedges
|
|
|
|
|
|||
|
Derivatives for trading
|
|
(
|
|
(
|
|||
|
Total Fair value of derivative financial assets/(liabilities)
|
€
|
€
(
|
€
|
€
(
|
|||
|
Financial derivative assets/(liabilities) - current
|
€
|
€
(
|
€
|
€
(
|
|||
|
Financial derivative assets/(liabilities) - non-current
|
€
|
€
(
|
€
|
€
(
|
|||
|
Derivative operating assets/(liabilities) - current
|
€
|
€
(
|
€
|
€
(
|
|||
|
Derivative operating assets/(liabilities) - non-current
|
€
|
€
(
|
€
|
€
(
|
|||
|
At December 31,
|
|||||||||||
|
2024
|
2023
|
||||||||||
|
Due within
one year
|
Due
between
one and
five
years
|
Total
|
Due within
one year
|
Due
between
one and
five
years
|
Total
|
||||||
|
(€ million)
|
|||||||||||
|
Currency risk management
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Interest rate risk management
|
|
|
|
|
|
|
|||||
|
Interest rate and currency risk management
|
|
|
|
|
|
|
|||||
|
Commodity price risk management
|
|
|
|
|
|
|
|||||
|
Total Notional amount
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Currency and interest rate risk
|
|||||
|
Change in ineffective portion
|
€
|
€
(
|
€
(
|
||
|
Net gains/(losses)
|
€
|
€
(
|
€
(
|
||
|
Years ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
(€ million)
|
|||||
|
Currency risk
|
|||||
|
(Increase)/decrease in Cost of revenues
|
€
|
€
(
|
€
(
|
||
|
Share of profit/(loss) of equity method investees
|
(
|
|
(
|
||
|
Interest rate risk
|
|||||
|
Share of profit/(loss) of equity method investees
|
|
|
(
|
||
|
Net financial income/(expenses)
|
(
|
|
|
||
|
Commodity price risk
|
|||||
|
(Increase)/decrease in Cost of revenues
|
(
|
(
|
|
||
|
Ineffectiveness and discontinued hedges
|
(
|
|
(
|
||
|
Tax expenses/(benefit)
|
|
|
(
|
||
|
Total recognized in the Consolidated Income Statement
|
€
(
|
€
(
|
€
|
||
|
18.
|
Cash and cash equivalents
|
|
At December 31,
|
|||
|
2024
|
2023
|
||
|
(€ million)
|
|||
|
Cash at banks
|
€
|
€
|
|
|
Money market securities measured at FVTPL
|
|
|
|
|
Other cash equivalents
|
|
|
|
|
Total Cash and cash equivalents
|
€
|
€
|
|
|
19.
|
Share-based compensation
|
|
2024
|
|||||||||||
|
PSU TSR
|
Weighted
average fair
value at the
grant date
(€)
|
PSU Synergies
|
Weighted
average fair
value at the
grant date
(€)
|
PSU
Compliance
|
Weighted
average fair
value at the
grant date
(€)
|
||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
|||||
|
Granted
|
|
|
|
|
|
|
|||||
|
Vested
|
(
|
|
(
|
|
(
|
|
|||||
|
Canceled
|
(
|
|
|
|
(
|
|
|||||
|
Forfeited
|
(
|
|
(
|
|
(
|
|
|||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
|||||
|
2024
|
|||||||||||
|
PSU
Electrification
|
Weighted
average fair
value at the
grant date
(€)
|
PSU AOI
|
Weighted
average fair
value at the
grant date
(€)
|
PRSU
|
Weighted
average fair
value at the
grant date
(€)
|
||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
|||||
|
Granted
|
|
|
|
|
|
|
|||||
|
Vested
|
(
|
|
|
|
(
|
|
|||||
|
Canceled
|
(
|
|
(
|
|
(
|
|
|||||
|
Forfeited
|
(
|
|
(
|
|
(
|
|
|||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
|||||
|
2023
|
|||||||||||
|
PSU TSR
|
Weighted
average fair
value at the
grant date
(€)
|
PSU Synergies
|
Weighted
average fair
value at the
grant date
(€)
|
PSU
Compliance
|
Weighted
average fair
value at the
grant date
(€)
|
||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
|||||
|
Granted
|
|
|
|
|
|
|
|||||
|
Vested
|
|
|
|
|
|
|
|||||
|
Canceled
|
|
|
|
|
|
|
|||||
|
Forfeited
|
(
|
|
(
|
|
(
|
|
|||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
|||||
|
2023
|
|||||||||||
|
PSU
Electrification
|
Weighted
average fair
value at the
grant date
(€)
|
PSU AOI
|
Weighted
average fair
value at the
grant date
(€)
|
PRSU
|
Weighted
average fair
value at the
grant date
(€)
|
||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
|||||
|
Granted
|
|
|
|
|
|
|
|||||
|
Vested
|
|
|
|
|
|
|
|||||
|
Canceled
|
|
|
|
|
|
|
|||||
|
Forfeited
|
(
|
|
(
|
|
|
|
|||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
|||||
|
2022
|
|||||||||||||||
|
PSU TSR
|
Weighted
average fair
value at the
grant date
(€)
|
PSU
Synergies
|
Weighted
average fair
value at the
grant date
(€)
|
PSU
Compliance
|
Weighted
average fair
value at the
grant date
(€)
|
PSU
Electrification
|
Weighted
average fair
value at the
grant date
(€)
|
||||||||
|
Outstanding
shares unvested
at January 1
|
|
€
|
|
€
|
|
€
|
|
€
|
|||||||
|
Granted
|
|
|
|
|
|
|
|
|
|||||||
|
Vested
|
|
|
|
|
|
|
|
|
|||||||
|
Canceled
|
|
|
|
|
|
|
|
|
|||||||
|
Forfeited
|
(
|
|
(
|
|
(
|
|
(
|
|
|||||||
|
Outstanding
shares unvested
at December 31
|
|
€
|
|
€
|
|
€
|
|
€
|
|||||||
|
2024
|
2023
|
2022
|
||||
|
Key assumptions
|
PSU TSR Awards Range
|
|||||
|
Grant date stock price
|
€
|
€
|
€
|
|||
|
Expected volatility
|
|
|
|
|||
|
Risk-free rate
|
|
|
|
|||
|
Expected dividend yields
|
|
|
|
|||
|
2024
|
2023
|
2022
|
|||||||||
|
RSUs
|
Weighted
average fair
value at the
grant date
(€)
|
RSUs
|
Weighted
average fair
value at the
grant date
(€)
|
RSUs
|
Weighted
average fair
value at the
grant date
(€)
|
||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
|||||
|
Granted
|
|
|
|
|
|
|
|||||
|
Vested
|
(
|
|
(
|
|
(
|
|
|||||
|
Canceled
|
(
|
|
|
|
|
|
|||||
|
Forfeited
|
(
|
|
(
|
|
(
|
|
|||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
|||||
|
2024
|
2023
|
2022
|
|||||||||
|
Replacement
Stellantis
RSU awards
|
Weighted
average fair
value at the
grant date
(€)
|
Replacement
Stellantis
RSU awards
|
Weighted
average fair
value at the
grant date
(€)
|
Replacement
Stellantis
RSU awards
|
Weighted
average fair
value at the
grant date
(€)
|
||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
|||||
|
Anti-dilution adjustment
|
|
|
|
|
|
|
|||||
|
Granted
|
|
|
|
|
|
|
|||||
|
Vested
|
|
|
(
|
|
(
|
|
|||||
|
Canceled
|
|
|
|
|
|
|
|||||
|
Forfeited
|
|
|
(
|
|
(
|
|
|||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
|||||
|
2024
|
2023
|
2022
|
||||||||||
|
Replacement
Stellantis RSU
awards
|
Weighted
average fair
value at the
grant date
(€)
|
Replacement
Stellantis RSU
awards
|
Weighted
average fair
value at the
grant date
(€)
|
Replacement
Stellantis RSU
awards
|
Weighted
average fair
value at the
grant date
(€)
|
|||||||
|
Outstanding shares unvested at
January 1
|
|
€
|
|
€
|
|
€
|
||||||
|
Anti-dilution adjustment
|
|
|
|
|
|
|
||||||
|
Granted
|
|
|
|
|
|
|
||||||
|
Vested
|
|
|
(
|
|
(
|
|
||||||
|
Canceled
|
|
|
|
|
|
|
||||||
|
Forfeited
|
|
|
|
|
(
|
|
||||||
|
Outstanding shares unvested at
December 31
|
|
€
|
|
€
|
|
€
|
||||||
|
20.
|
Employee benefits liabilities
|
|
At December 31,
|
||||||||||||
|
2024
|
2023
|
|||||||||||
|
Current
|
Non-
current
|
Total
|
Current
|
Non-
current
|
Total
|
|||||||
|
(€ million)
|
||||||||||||
|
Pension benefits
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
Health care and life insurance plans
|
|
|
|
|
|
|
||||||
|
Other post-employment benefits
|
|
|
|
|
|
|
||||||
|
Other provisions for employees
|
|
|
|
|
|
|
||||||
|
Total Employee benefits liabilities
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
At December 31,
|
||||
|
2024
|
2023
|
|||
|
(€ million)
|
||||
|
Present value of defined benefit obligations:
|
||||
|
Pension benefits
|
€
|
€
|
||
|
Health care and life insurance plans
|
|
|
||
|
Other post-employment benefits
|
|
|
||
|
Total present value of defined benefit obligations (a)
|
|
|
||
|
Fair value of plan assets (b)
|
|
|
||
|
Asset ceiling (c)
|
|
|
||
|
Total net defined benefit plans (a - b + c)
|
|
|
||
|
of which:
|
||||
|
Net defined benefit liability (d)
|
|
|
||
|
Defined benefit plan asset (Note 16)
|
(
|
(
|
||
|
Other provisions for employees (e)
|
|
|
||
|
Total Employee benefits liabilities (d + e)
|
€
|
€
|
||
|
Expected benefit
payments
|
||
|
(€ million)
|
||
|
2025
|
€
|
|
|
2026
|
€
|
|
|
2027
|
€
|
|
|
2028
|
€
|
|
|
2029
|
€
|
|
|
2030-2034
|
€
|
|
2024
|
2023
|
|||||||||||||||||||
|
U.S. and
Canada
|
UK
|
France
and
Germany
|
Other
|
Total
|
U.S. and
Canada
|
UK
|
France
and
Germany
|
Other
|
Total
|
|||||||||||
|
(€ million)
|
||||||||||||||||||||
|
Projected benefit obligation
|
||||||||||||||||||||
|
At beginning of period:
Present value
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
||||||||||
|
Effect of changes in scope of
consolidation and other
|
|
|
|
|
|
(
|
|
(
|
|
(
|
||||||||||
|
Service cost
|
(
|
|
(
|
(
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||
|
Interest cost
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||
|
Benefit payments for the year
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Participant contributions
|
(
|
|
|
|
(
|
(
|
|
|
|
(
|
||||||||||
|
Actuarial gains and (losses)
|
|
(
|
(
|
(
|
|
(
|
|
(
|
(
|
(
|
||||||||||
|
Demographic assumptions
and experience
|
(
|
(
|
|
|
|
|
(
|
(
|
(
|
(
|
||||||||||
|
Financial assumptions
|
|
(
|
(
|
(
|
|
(
|
|
(
|
|
(
|
||||||||||
|
Effect of changes in exchange
rates
|
(
|
(
|
|
|
(
|
|
(
|
|
(
|
|
||||||||||
|
Past service cost
|
(
|
(
|
|
(
|
(
|
(
|
(
|
|
|
(
|
||||||||||
|
Effect of curtailments and
settlements/Other
|
|
|
|
|
|
(
|
|
|
|
(
|
||||||||||
|
At period-end: Present value
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
||||||||||
|
Plan Assets
|
||||||||||||||||||||
|
At beginning of period: Fair
value
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||
|
Effect of changes in scope of
consolidation and other
|
(
|
|
|
(
|
(
|
|
|
|
|
|
||||||||||
|
Expected return on assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Participant contributions
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Administrative Expenses
|
(
|
(
|
|
(
|
(
|
(
|
(
|
|
|
(
|
||||||||||
|
Actuarial gains and (losses)
|
(
|
(
|
|
|
(
|
|
(
|
(
|
(
|
|
||||||||||
|
Effect of changes in exchange
rates
|
|
|
|
|
|
(
|
|
|
|
(
|
||||||||||
|
Employer contributions
|
|
|
|
(
|
|
|
|
|
|
|
||||||||||
|
Benefit payments for the year
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||
|
At period-end: Fair value
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||
|
2024
|
2023
|
|||||||||||||||||||
|
U.S. and
Canada
|
UK
|
France
and
Germany
|
Other
|
Total
|
U.S. and
Canada
|
UK
|
France
and
Germany
|
Other
|
Total
|
|||||||||||
|
(€ million)
|
||||||||||||||||||||
|
Present value of
projected benefit
obligation
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
||||||||||
|
Fair value of plan assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net (liability) asset
recognized in the balance
sheet before minimum
funding requirement
(IFRIC 14)
|
(
|
|
(
|
(
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||
|
Minimum funding
requirement liability
(IFRIC 14)
|
(
|
|
|
|
(
|
(
|
|
|
|
(
|
||||||||||
|
Net (liability) asset
recognized in the balance
sheet
|
(
|
|
(
|
(
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||
|
Of which, liability
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||
|
Of which, asset
|
|
|
|
(
|
|
|
|
|
(
|
|
||||||||||
|
Years ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
(€ million)
|
||||||
|
Current service cost
|
€
|
€
|
€
|
|||
|
Interest expense
|
|
|
|
|||
|
Interest income
|
(
|
(
|
(
|
|||
|
Other administration costs
|
|
|
|
|||
|
Past service costs/(credits) and (gains)/losses arising from settlements/curtailments
|
|
|
|
|||
|
Interest expense on asset ceiling
|
|
|
|
|||
|
Total recognized in the Consolidated Income Statement
|
€
|
€
|
€
|
|||
|
At December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Amount
|
of which have a
quoted market
price in an active
market
|
Amount
|
of which have a
quoted market
price in an active
market
|
|||||
|
(€ million)
|
||||||||
|
Cash and cash equivalents
|
€
|
€
|
€
|
€
|
||||
|
U.S. equity securities
|
|
|
|
|
||||
|
Non-U.S. equity securities
|
|
|
|
|
||||
|
Equity commingled funds
|
|
|
|
|
||||
|
Equity instruments
|
|
|
|
|
||||
|
Government securities
|
|
|
|
|
||||
|
Corporate bonds (including convertible and high yield bonds)
|
|
|
|
|
||||
|
Other fixed income
|
|
|
|
|
||||
|
Fixed income securities
|
|
|
|
|
||||
|
Private equity funds
|
|
|
|
|
||||
|
Diversified Commingled funds
|
|
|
|
|
||||
|
Real estate funds
|
|
|
|
|
||||
|
Hedge funds
|
|
|
|
|
||||
|
Investment funds
|
|
|
|
|
||||
|
Insurance contracts and other
|
(
|
(
|
|
|
||||
|
Total fair value of plan assets
|
€
|
€
|
€
|
€
|
||||
|
At December 31,
|
||||||||||||||||||||
|
2024
|
2023
|
|||||||||||||||||||
|
U.S.
|
Canada
|
UK
|
France
|
Germany
|
U.S.
|
Canada
|
UK
|
France
|
Germany
|
|||||||||||
|
Discount rate
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Future salary
increase rate
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2024
|
||||||||||
|
U.S.
|
Canada
|
UK
|
France
|
Germany
|
||||||
|
Life Expectancy at Age 65
|
||||||||||
|
Male retiring in 25 years (Aged 40)
|
|
|
|
N/A
|
|
|||||
|
Female retiring in 25 years (Aged 40)
|
|
|
|
N/A
|
|
|||||
|
Male retiring today (Aged 65)
|
|
|
|
|
|
|||||
|
Female retiring today (Aged 65)
|
|
|
|
|
|
|||||
|
Expected benefit
payments
|
||
|
(€ million)
|
||
|
2025
|
€
|
|
|
2026
|
€
|
|
|
2027
|
€
|
|
|
2028
|
€
|
|
|
2029
|
€
|
|
|
2030-2034
|
€
|
|
2024
|
2023
|
|||
|
(€ million)
|
||||
|
Present value of obligations at January 1
|
€
|
€
|
||
|
Included in the Consolidated Income Statement
|
|
|
||
|
Included in Other comprehensive income:
|
||||
|
Actuarial (gains)/losses from:
|
||||
|
- Demographic and other assumptions
|
(
|
(
|
||
|
- Financial assumptions
|
(
|
|
||
|
Effect of movements in exchange rates
|
|
(
|
||
|
Other:
|
||||
|
Benefits paid
|
(
|
(
|
||
|
December 31
|
€
|
€
|
||
|
Years ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
(€ million)
|
||||||
|
Current service cost
|
€
|
€
|
€
|
|||
|
Interest expense
|
|
|
|
|||
|
Past service costs/(credits) and losses/(gains) arising from settlements
|
|
|
|
|||
|
Total recognized in the Consolidated Income Statement
|
€
|
€
|
€
|
|||
|
At December 31,
|
|||||||
|
2024
|
2023
|
||||||
|
U.S.
|
Canada
|
U.S.
|
Canada
|
||||
|
Discount rate
|
|
|
|
|
|||
|
Salary growth
|
|
|
|
|
|||
|
Weighted average ultimate healthcare cost trend rate
|
|
|
|
|
|||
|
2024
|
2023
|
|||
|
(€ million)
|
||||
|
Present value of obligations at January 1
|
€
|
€
|
||
|
Included in the Consolidated Income Statement
|
(
|
|
||
|
Included in Other comprehensive income:
|
||||
|
Actuarial (gains)/losses from:
|
||||
|
- Demographic and other assumptions
|
(
|
(
|
||
|
- Financial assumptions
|
|
(
|
||
|
Effect of movements in exchange rates
|
(
|
(
|
||
|
Other:
|
||||
|
Benefits paid
|
(
|
(
|
||
|
Other changes
|
(
|
|
||
|
Present value of obligations at December 31
|
€
|
€
|
||
|
Years ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
(€ million)
|
||||||
|
Current service cost
|
€
|
€
|
€
|
|||
|
Interest expense
|
|
|
|
|||
|
Past service costs/(credits) and losses/(gains) arising from settlements
|
(
|
(
|
(
|
|||
|
Total recognized in the Consolidated Income Statement
|
€
(
|
€
|
€
(
|
|||
|
21.
|
Provisions
|
|
At December 31,
|
||||||||||||
|
2024
|
2023
|
|||||||||||
|
Current
|
Non-
current
|
Total
|
Current
|
Non-
current
|
Total
|
|||||||
|
(€ million)
|
||||||||||||
|
Product warranty and recall campaigns
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
Sales incentives
|
|
|
|
|
|
|
||||||
|
Restructuring
|
|
|
|
|
|
|
||||||
|
Legal proceedings and disputes
|
|
|
|
|
|
|
||||||
|
Commercial risks
|
|
|
|
|
|
|
||||||
|
Other risks
|
|
|
|
|
|
|
||||||
|
Total Provisions
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
At January
1, 2024
|
Additional
provisions
|
Settlements
|
Unused
amounts
|
Translation
differences
|
Transfer to
Liabilities
held for
sale
|
Change in
scope
|
Other
|
At
December
31, 2024
|
||||||||||
|
(€ million)
|
||||||||||||||||||
|
Product warranty and
recall campaigns
|
€
|
€
|
€
(
|
€
(
|
€
|
€
(
|
€
(
|
€
|
€
|
|||||||||
|
Sales incentives
|
|
|
(
|
(
|
|
(
|
|
|
|
|||||||||
|
Restructuring costs
|
|
|
(
|
(
|
|
|
(
|
|
|
|||||||||
|
Legal proceedings and
disputes
|
|
|
(
|
(
|
(
|
|
(
|
|
|
|||||||||
|
Commercial risks
|
|
|
(
|
(
|
|
|
(
|
|
|
|||||||||
|
Other risks
|
|
|
(
|
(
|
|
|
|
|
|
|||||||||
|
Total Provisions
|
€
|
€
|
€
(
|
€
(
|
€
|
€
(
|
€
(
|
€
|
€
|
|||||||||
|
At January
1, 2023
|
Additional
provisions
|
Settlements
|
Unused
amounts
|
Translation
differences
|
Transfer to
Liabilities
held for
sale
|
Change in
scope
|
Other
|
At
December
31, 2023
|
||||||||||
|
(€ million)
|
||||||||||||||||||
|
Product warranty and
recall campaigns
|
€
|
€
|
€
(
|
€
(
|
€
(
|
€
(
|
€
|
€
|
€
|
|||||||||
|
Sales incentives
|
|
|
(
|
(
|
(
|
|
|
(
|
|
|||||||||
|
Restructuring costs
|
|
|
(
|
(
|
(
|
|
(
|
|
|
|||||||||
|
Legal proceedings and
disputes
|
|
|
(
|
(
|
|
|
(
|
|
|
|||||||||
|
Commercial risks
|
|
|
(
|
(
|
(
|
|
|
(
|
|
|||||||||
|
Other risks
|
|
|
(
|
(
|
(
|
|
(
|
(
|
|
|||||||||
|
Total Provisions
|
€
|
€
|
€
(
|
€
(
|
€
(
|
€
(
|
€
(
|
€
|
€
|
|||||||||
|
22.
|
Debt
|
|
At December 31,
|
||||||||||||||||||||
|
2024
|
2023
|
|||||||||||||||||||
|
Due
within
one year
(current)
|
Due
between
one and
five years
|
Due
beyond
five years
|
Total
(non-
current)
|
Total
Debt
|
Due
within
one year
(current)
|
Due
between
one and
five years
|
Due
beyond
five
years
|
Total
(non-
current)
|
Total
Debt
|
|||||||||||
|
(€ million)
|
||||||||||||||||||||
|
Notes
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||
|
Borrowings from
banks
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Asset-backed
financing
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Lease liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Other debt
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total Debt
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||
|
At December 31,
|
||||||||||||
|
(€ million)
|
Currency
|
Face value of
outstanding
notes
(million)
|
Coupon
%
|
Maturity
|
2024
|
2023
|
||||||
|
Stellantis (Peugeot S.A. issuances):
|
||||||||||||
|
STELLANTIS N.V. (Peugeot S.A.) 2017
|
EUR
|
|
|
Q1/2024
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.) 2017
|
EUR
|
|
|
Q1/2024
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.) 2018
|
EUR
|
|
|
Q1/2025
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.) 2019
|
EUR
|
|
|
Q3/2029
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.) 2020
|
EUR
|
|
|
Q2/2026
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.)
Schuldschein 2019
|
EUR
|
|
|
Q2/2026
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.)
Schuldschein 2019
|
EUR
|
|
|
Q2/2027
|
|
|
||||||
|
STELLANTIS N.V. (Peugeot S.A.)
Schuldschein 2019
|
EUR
|
|
Euribor
6M +
|
Q2/2026
|
|
|
||||||
|
Medium Term Note Programme
(1)
:
|
||||||||||||
|
STELLANTIS N.V. (FCA N.V.) 2016
|
EUR
|
|
|
Q1/2024
|
|
|
||||||
|
STELLANTIS N.V. (FCA N.V.) 2020
|
EUR
|
|
|
Q1/2026
|
|
|
||||||
|
STELLANTIS N.V. (FCA N.V.) 2020
|
EUR
|
|
|
Q3/2028
|
|
|
||||||
|
STELLANTIS N.V. 2021
|
EUR
|
|
|
Q1/2027
|
|
|
||||||
|
STELLANTIS N.V. 2021
|
EUR
|
|
|
Q1/2029
|
|
|
||||||
|
STELLANTIS N.V. 2021
|
EUR
|
|
|
Q2/2033
|
|
|
||||||
|
STELLANTIS N.V. 2022
|
EUR
|
|
|
Q2/2032
|
|
|
||||||
|
STELLANTIS N.V. 2023 - green bond
|
EUR
|
|
|
Q1/2030
|
|
|
||||||
|
STELLANTIS N.V. 2023
|
EUR
|
|
|
Q2/2031
|
|
|
||||||
|
STELLANTIS N.V. 2024
|
EUR
|
|
|
Q3/2030
|
|
|
||||||
|
STELLANTIS N.V. 2024 - green bond
|
EUR
|
|
|
Q1/2036
|
|
|
||||||
|
STELLANTIS N.V. 2024
|
EUR
|
|
|
Q4/2028
|
|
|
||||||
|
STELLANTIS N.V. 2024
|
EUR
|
|
|
Q1/2034
|
|
|
||||||
|
Other Notes:
|
||||||||||||
|
STELLANTIS FINANCE U.S. 2021
|
U.S $
|
|
|
Q1/2027
|
|
|
||||||
|
STELLANTIS FINANCE U.S. 2021
|
U.S $
|
|
|
Q3/2031
|
|
|
||||||
|
STELLANTIS FINANCE U.S. 2022
|
U.S. $
|
|
|
Q1/2028
|
|
|
||||||
|
STELLANTIS FINANCE U.S. 2022
|
U.S. $
|
|
|
Q3/2032
|
|
|
||||||
|
GIE PSA Trésorerie 2003
|
EUR
|
|
|
Q3/2033
|
|
|
||||||
|
Total Notes
|
€
|
€
|
||||||||||
|
At December 31,
|
||||||||||
|
(€ million)
|
Currency
|
Interest rate %
|
Maturity
(1)
|
2024
|
2023
|
|||||
|
Warehouse Credit
Facilities:
|
||||||||||
|
SFS Funding I
|
USD
|
CP/SOFR+spread
|
Q2/2026
|
|
|
|||||
|
SFS Funding II
|
USD
|
CP/SOFR+spread
|
Q3/2024
|
|
|
|||||
|
FIARC
|
USD
|
SOFR+spread
|
Q2/2025
|
|
|
|||||
|
SFMOT Floorplan Facility
|
USD
|
CP/SOFR+spread
|
Q2/2026
|
|
|
|||||
|
Term Notes:
|
||||||||||
|
Term Notes 2017-2020
|
USD
|
|
Q2/2027
|
|
|
|||||
|
FIAOT 2021-1
|
USD
|
|
Q2/2028
|
|
|
|||||
|
FIAOT 2021-2
|
USD
|
|
Q4/2028
|
|
|
|||||
|
FIAOT 2022-1
|
USD
|
|
Q2/2029
|
|
|
|||||
|
FIAOT 2022-2
|
USD
|
|
Q4/2029
|
|
|
|||||
|
FIAOT 2023-1
|
USD
|
|
Q1/2031
|
|
|
|||||
|
SFAST 2023-1
|
USD
|
|
Q1/2031
|
|
|
|||||
|
SFAST 2024-1
|
USD
|
|
Q1/2032
|
|
|
|||||
|
SFAST 2024-2
|
USD
|
|
Q1/2032
|
|
|
|||||
|
SFAST 2024-3
|
USD
|
|
Q4/2032
|
|
|
|||||
|
Term Loans:
|
||||||||||
|
SFAF LLC
|
USD
|
|
Q4/2031
|
|
|
|||||
|
SFAF 2024-2
|
USD
|
|
Q1/2032
|
|
|
|||||
|
SFALV 2024-1
|
USD
|
|
Q1/2030
|
|
|
|||||
|
Total
|
€
|
€
|
||||||||
|
At December 31,
|
||||
|
2024
|
2023
|
|||
|
(€ million)
|
||||
|
Long-term debt (non-current)
|
€
|
€
|
||
|
Short-term debt and current portion of long-term debt (current)
|
€
|
€
|
||
|
At December 31, 2024
|
||
|
(€ million)
|
||
|
Due within one year
|
€
|
|
|
Due between one and five years
|
|
|
|
Due beyond five years
|
|
|
|
Total undiscounted lease liabilities
|
€
|
|
23.
|
Trade Payables
|
|
At December 31, 2024
|
At January 1, 2024
|
|||
|
(€ million)
|
||||
|
Presented within trade payables
|
€
|
€
|
||
|
Of which suppliers have received payment
|
|
|
||
|
At December 31, 2024
|
At January 1, 2024
|
|||
|
(days)
|
||||
|
Liabilities that are part of the arrangement
|
|
|
||
|
Comparable trade payables that are not part of an arrangement
(1)
|
|
|
||
|
24.
|
Other liabilities
|
|
At December 31,
|
||||||||||||
|
2024
|
2023
|
|||||||||||
|
Current
|
Non-
current
|
Total
|
Current
|
Non-
current
|
Total
|
|||||||
|
(€ million)
|
||||||||||||
|
Payables for buy-back agreements
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
Accrued expenses and deferred income
|
|
|
|
|
|
|
||||||
|
Indirect tax payables
|
|
|
|
|
|
|
||||||
|
Payables to personnel
|
|
|
|
|
|
|
||||||
|
Social security payables
|
|
|
|
|
|
|
||||||
|
Construction contract liabilities
(Note 14)
(1)
|
|
|
|
|
|
|
||||||
|
Service contract liability
|
|
|
|
|
|
|
||||||
|
Derivatives operating liability
|
|
|
|
|
|
|
||||||
|
Other
|
|
|
|
|
|
|
||||||
|
Total Other liabilities
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||
|
At December 31,
|
||||||||||||||||||||
|
2024
|
2023
|
|||||||||||||||||||
|
Total
due within
one year
(Current)
|
Due
between
one and
five
years
|
Due
beyond
five
years
|
Total due
after one
year
(Non-
Current)
|
Total
|
Total
due within
one year
(Current)
|
Due
between
one and
five
years
|
Due
beyond
five
years
|
Total due
after one
year
(Non-
Current)
|
Total
|
|||||||||||
|
(€ million)
|
||||||||||||||||||||
|
Other liabilities (excluding
Accrued expenses, deferred
income and service contract
liability)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||
|
At January 1,
2024
|
Advances
received from
customers
|
Amounts
recognized
within revenue
|
Transfers to
Assets/
(Liabilities)
held for sale
|
Other changes
|
At December
31, 2024
|
|||||||
|
(€ million)
|
||||||||||||
|
Service contract liability
|
€
|
€
|
€
(
|
€
|
€
(
|
€
|
||||||
|
25.
|
Fair value measurement
|
|
At December 31,
|
|||||||||||||||||
|
2024
|
2023
|
||||||||||||||||
|
Note
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||
|
(€ million)
|
|||||||||||||||||
|
Financial securities and equity
instruments measured at FVOCI
|
13
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
Financial securities and equity
instruments measured at FVPL
|
13
|
|
|
|
|
|
|
|
|
||||||||
|
Derivative financial assets
|
17
|
|
|
|
|
|
|
|
|
||||||||
|
Derivative operating assets
|
17
|
|
|
|
|
|
|
|
|
||||||||
|
Collateral deposits
|
13
|
|
|
|
|
|
|
|
|
||||||||
|
Receivables from financing
activities
|
16
|
|
|
|
|
|
|
|
|
||||||||
|
Trade receivables
|
16
|
|
|
|
|
|
|
|
|
||||||||
|
Other receivables
|
16
|
|
|
|
|
|
|
|
|
||||||||
|
Money market securities
|
18
|
|
|
|
|
|
|
|
|
||||||||
|
Total Assets
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Derivative financial liabilities
|
17
|
|
|
|
|
|
|
|
|
||||||||
|
Derivative operating liabilities
|
17
|
|
|
|
|
|
|
|
|
||||||||
|
Total Liabilities
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Receivables
from
financing
activities
|
Financial
securities
|
Derivative
financial
assets/
(liabilities)
|
Money
market
securities
|
Other
receivables
|
||||||
|
(€ million)
|
||||||||||
|
At January 1, 2024
|
€
|
€
|
€
(
|
€
|
€
|
|||||
|
Change in scope of consolidation
|
|
(
|
|
|
|
|||||
|
Gains/(Losses) recognized in Consolidated Income
Statement
|
|
(
|
|
|
(
|
|||||
|
Gains/(Losses) recognized in Other comprehensive
income
|
|
(
|
|
|
|
|||||
|
Issues/Settlements
|
(
|
|
|
|
|
|||||
|
Purchases/Sales
|
|
(
|
|
|
|
|||||
|
At December 31, 2024
|
€
|
€
|
€
(
|
€
|
€
|
|||||
|
Receivables
from
financing
activities
|
Financial
securities
|
Derivative
financial
assets/
(liabilities)
|
Money
market
securities
|
Other
receivables
|
||||||
|
(€ million)
|
||||||||||
|
At January 1, 2023
|
€
|
€
|
€
(
|
€
|
€
|
|||||
|
Change in scope of consolidation
|
|
(
|
|
|
|
|||||
|
Gains/(Losses) recognized in Consolidated Income
Statement
|
|
|
|
|
(
|
|||||
|
Gains/(Losses) recognized in Other comprehensive
income
|
|
(
|
|
|
|
|||||
|
Issues/Settlements
|
(
|
|
|
|
|
|||||
|
Purchases/Sales
|
|
|
|
|
|
|||||
|
Transfers from Level 3
|
|
|
|
(
|
|
|||||
|
At December 31, 2023
|
€
|
€
|
€
(
|
€
|
€
|
|||||
|
At December 31,
|
|||||||||
|
2024
|
2023
|
||||||||
|
Note
|
Carrying
amount
|
Fair
Value
|
Carrying
amount
|
Fair
Value
|
|||||
|
(€ million)
|
|||||||||
|
Dealer financing
|
€
|
€
|
€
|
€
|
|||||
|
Retail financing
|
|
|
|
|
|||||
|
Finance lease
|
|
|
|
|
|||||
|
Other receivables from financing activities
|
|
|
|
|
|||||
|
Total Receivables from financing activities
(1)
|
16
|
€
|
€
|
€
|
€
|
||||
|
Asset-backed financing
|
€
|
€
|
€
|
€
|
|||||
|
Notes
|
|
|
|
|
|||||
|
Borrowings from banks & Other debt
|
|
|
|
|
|||||
|
Total Debt, excluding Lease liabilities
|
22
|
€
|
€
|
€
|
€
|
||||
|
26.
|
Related party transactions
|
|
Years ended December 31,
|
||||||||||||||||||||||||
|
2024
|
2023
|
2022
|
||||||||||||||||||||||
|
Net
Revenues
|
Cost of
revenues
|
Selling,
general
and
other
costs, net
|
Net
Financial
expenses/
(income)
|
Net
Revenues
|
Cost of
revenues
|
Selling,
general
and
other
costs, net
|
Net
Financial
expenses/
(income)
|
Net
Revenues
|
Cost of
revenues
|
Selling,
general
and
other
costs, net
|
Net
Financial
expenses
|
|||||||||||||
|
(€ million)
|
||||||||||||||||||||||||
|
Tofas
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||||
|
FCA Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Leasys
|
|
|
(
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Finance companies in
partnership with SCF
and BNPP PF
(1)
|
|
|
(
|
|
|
|
(
|
|
|
|
|
(
|
||||||||||||
|
Other
|
|
|
|
(
|
|
|
(
|
(
|
|
|
|
(
|
||||||||||||
|
Total joint
arrangements
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other
|
|
|
(
|
(
|
|
|
|
(
|
|
|
|
|
||||||||||||
|
Total associates
|
|
|
(
|
(
|
|
|
|
(
|
|
|
|
|
||||||||||||
|
CNHI
|
|
|
|
|
|
|
(
|
|
|
|
|
|
||||||||||||
|
Iveco
|
|
|
|
|
|
|
(
|
|
|
|
(
|
|
||||||||||||
|
Ferrari N.V.
|
|
|
(
|
|
|
|
(
|
|
|
|
|
|
||||||||||||
|
Directors and Key
Management
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total CNHI, Ferrari,
Directors and other
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total unconsolidated
subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
(
|
||||||||||||
|
Total transactions
with related parties
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||||||
|
Total for the
Company
|
€
|
€
|
€
|
€
(
|
€
|
€
|
€
|
€
(
|
€
|
€
|
€
|
€
|
||||||||||||
|
At December 31,
|
||||||||||||||||
|
2024
|
2023
|
|||||||||||||||
|
Trade and
other
receivables
|
Trade
payables and
other liabilities
|
Asset-
backed
financing
|
Debt
(1)
|
Trade
and other
receivables
|
Trade
payables and
other liabilities
|
Asset-
backed
financing
|
Debt
(1)
|
|||||||||
|
(€ million)
|
||||||||||||||||
|
Tofas
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
Leasys
|
|
|
|
|
|
|
|
|
||||||||
|
Finance companies in partnership
with SCF and BNPP PF
|
|
|
|
|
|
|
|
|
||||||||
|
Other
|
|
|
|
|
|
|
|
|
||||||||
|
Total joint arrangements
|
|
|
|
|
|
|
|
|
||||||||
|
Other
|
|
|
|
|
|
|
|
|
||||||||
|
Total associates
|
|
|
|
|
|
|
|
|
||||||||
|
CNHI
|
|
|
|
|
|
|
|
|
||||||||
|
Iveco
|
|
|
|
|
|
|
|
|
||||||||
|
Ferrari N.V.
|
|
|
|
|
|
|
|
|
||||||||
|
Other
|
|
|
|
(
|
|
|
|
|
||||||||
|
Total CNHI, Ferrari N.V. and
other
|
|
|
|
(
|
|
|
|
|
||||||||
|
Total unconsolidated
subsidiaries
|
|
|
|
|
|
|
|
|
||||||||
|
Total originating from related
parties
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
Total for the Company
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
||||||||
|
27.
|
Guarantees granted, commitments and contingent liabilities
|
|
(€ million)
|
||
|
2025
|
€
|
|
|
2026
|
€
|
|
|
2027
|
€
|
|
|
2028
|
€
|
|
|
2029
|
€
|
|
|
2030 and thereafter
|
€
|
|
28.
|
Equity
|
|
Common Shares
|
Special Voting
Shares A
|
Total
|
||||
|
Balance at January 1, 2024
|
|
|
|
|||
|
Issuance of special voting shares
|
|
|
|
|||
|
Purchase of treasury shares
|
(
|
(
|
(
|
|||
|
Treasury shares assigned to long-term incentive plans participants
|
|
|
|
|||
|
Shares issued for long-term incentive plans and employee-share
purchase plan
|
|
|
|
|||
|
Balance at December 31, 2024
|
|
|
|
|
Dates right subscribed
|
From November 5 to November 18,
2024
|
From November 13 to November 30,
2023
|
|
Employee subscription price
|
€
|
€
|
|
Lock-up period
|
|
|
|
Years ended December 31,
|
||||||||||||||||||
|
2024
|
2023
|
2022
|
||||||||||||||||
|
Pre-tax
balance
|
Tax
income/
(expense)
|
Net
balance
|
Pre-tax
balance
|
Tax
income/
(expense)
|
Net
balance
|
Pre-tax
balance
|
Tax
income/
(expense)
|
Net
balance
|
||||||||||
|
(€ million)
|
||||||||||||||||||
|
Fair value remeasurement of
cash flow hedges
|
|
(
|
|
(
|
|
(
|
(
|
|
(
|
|||||||||
|
Gains and losses from
remeasurement of
financial assets
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Actuarial gains and losses on
defined benefit
pension obligations
|
€
(
|
€
|
€
(
|
€
(
|
€
|
€
(
|
€
|
€
(
|
€
|
|||||||||
|
Exchange differences on
translating foreign
operations
|
|
|
|
(
|
|
(
|
|
|
|
|||||||||
|
Share of Other comprehensive
income/(loss) for equity method
investees
|
|
|
|
(
|
|
(
|
(
|
|
(
|
|||||||||
|
Total Other comprehensive
income/(loss)
|
€
|
€
(
|
€
|
€
(
|
€
|
€
(
|
€
|
€
(
|
€
|
|||||||||
|
29.
|
Earnings per share
|
|
Years ended December 31,
|
|||||||
|
2024
|
2023
|
2022
|
|||||
|
Net profit attributable to owners of the parent
|
million
|
€
|
€
|
€
|
|||
|
Weighted average number of shares outstanding
|
thousand
|
|
|
|
|||
|
Basic earnings per share
|
€
|
€
|
€
|
€
|
|||
|
Years ended December 31,
|
|||||||
|
2024
|
2023
|
2022
|
|||||
|
Net profit attributable to owners of the parent
|
million
|
€
|
€
|
€
|
|||
|
Weighted average number of shares outstanding
|
thousand
|
|
|
|
|||
|
Number of shares deployable for share-based compensation
|
thousand
|
|
|
|
|||
|
Weighted average number of shares outstanding for diluted earnings
per share
|
thousand
|
|
|
|
|||
|
Diluted earnings per share
|
€
|
€
|
€
|
€
|
|||
|
30.
|
Segment reporting
|
|
2024
|
North
America
|
Enlarged
Europe
|
Middle
East &
Africa
|
South
America
|
China and
India &
Asia Pacific
|
Maserati
|
Other
activities
|
Unallocated
items &
eliminations
|
Stellantis
|
|||||||||
|
(€ million)
|
||||||||||||||||||
|
Net revenues from external
customers
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Net revenues from
transactions with other
segments
|
|
|
(
|
(
|
|
|
|
(
|
—
|
|||||||||
|
Net revenues
|
|
|
|
|
|
|
|
(
|
|
|||||||||
|
Net profit/(loss)
|
€
|
|||||||||||||||||
|
Tax expense/(benefit)
|
€
(
|
|||||||||||||||||
|
Net financial expenses/
(income)
|
€
(
|
|||||||||||||||||
|
Operating income/(loss)
|
€
|
|||||||||||||||||
|
Adjustments:
|
||||||||||||||||||
|
Restructuring and other
costs, net of reversals
(1)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Impairment expense and
supplier obligations
(2)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Takata recall campaign
(3)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Lifetime onerous
contracts
(4)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Other
(5)
|
€
|
€
(
|
€
|
€
|
€
(
|
€
|
€
|
€
|
€
|
|||||||||
|
Total adjustments
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Adjusted operating income
|
€
|
€
|
€
|
€
|
€
(
|
€
(
|
€
|
€
(
|
€
|
|||||||||
|
Share of profit/(loss) of
equity method investees
|
€
(
|
€
(
|
€
|
€
|
€
(
|
€
|
€
|
€
|
€
(
|
|||||||||
|
2023
|
North
America
|
Enlarged
Europe
|
Middle
East &
Africa
|
South
America
|
China and
India &
Asia Pacific
|
Maserati
|
Other
activities
|
Unallocated
items &
eliminations
|
Stellantis
|
|||||||||
|
(€ million)
|
||||||||||||||||||
|
Net revenues from external
customers
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
(
|
€
|
|||||||||
|
Net revenues from
transactions with other
segments
|
|
|
|
(
|
|
|
|
(
|
—
|
|||||||||
|
Net revenues
|
|
|
|
|
|
|
|
(
|
|
|||||||||
|
Net profit/(loss)
|
€
|
|||||||||||||||||
|
Tax expense/(benefit)
|
€
|
|||||||||||||||||
|
Net financial expenses/
(income)
|
€
(
|
|||||||||||||||||
|
Operating income/(loss)
|
€
|
|||||||||||||||||
|
Adjustments:
|
||||||||||||||||||
|
Restructuring and other
costs, net of reversals
(1)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Collective agreements
related costs
(2)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Argentina currency
devaluation
(3)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Impairment expense and
supplier obligations
(4)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Reorganization of financial
services
(5)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Takata recall campaign
|
€
|
€
(
|
€
|
€
|
€
|
€
|
€
|
€
|
€
(
|
|||||||||
|
Patents litigation
(6)
|
€
(
|
€
(
|
€
|
€
(
|
€
|
€
|
€
|
€
|
€
(
|
|||||||||
|
Gains on disposal of equity
investments and other
assets
(7)
|
€
(
|
€
(
|
€
|
€
|
€
(
|
€
|
€
(
|
€
|
€
(
|
|||||||||
|
Other
(8)
|
€
|
€
|
€
|
€
(
|
€
(
|
€
|
€
(
|
€
|
€
|
|||||||||
|
Total adjustments
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Adjusted operating income
|
€
|
€
|
€
|
€
|
€
|
€
|
€
(
|
€
(
|
€
|
|||||||||
|
Share of profit/(loss) of
equity method investees
|
€
(
|
€
(
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
2022
|
North
America
|
Enlarged
Europe
|
Middle
East &
Africa
|
South
America
|
China and
India &
Asia Pacific
|
Maserati
|
Other
activities
|
Unallocated
items &
eliminations
|
Stellantis
|
|||||||||
|
(€ million)
|
||||||||||||||||||
|
Net revenues from external
customers
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Net revenues from transactions
with other segments
|
|
|
|
(
|
|
(
|
|
(
|
—
|
|||||||||
|
Net revenues
|
|
|
|
|
|
|
|
(
|
|
|||||||||
|
Net profit/(loss)
|
€
|
|||||||||||||||||
|
Tax expense/(benefit)
|
€
|
|||||||||||||||||
|
Net financial expenses/
(income)
|
€
|
|||||||||||||||||
|
Operating income/(loss)
|
€
|
|||||||||||||||||
|
Adjustments:
|
||||||||||||||||||
|
Restructuring costs and other
costs, net of reversals
(1)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Takata recall campaign
(2)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
CAFE penalty rate
(3)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Change in estimate of non-
contractual warranties
(4)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Impairment of GAC-
Stellantis JV
(5)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Impairment expense and
supplier obligations
(6)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Patents litigation
(7)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Write down of FCA Bank
investment
(8)
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Other
(9)
|
€
(
|
€
(
|
€
(
|
€
|
€
|
€
|
€
|
€
|
€
(
|
|||||||||
|
Total adjustments
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
|||||||||
|
Adjusted operating income
|
€
|
€
|
€
|
€
|
€
|
€
|
€
|
€
(
|
€
|
|||||||||
|
Share of profit/(loss) of equity
method investees
|
€
(
|
€
(
|
€
|
€
|
€
(
|
€
|
€
|
€
|
€
|
|||||||||
|
At December 31,
|
||||
|
2024
|
2023
|
|||
|
(€ million)
|
||||
|
North America
(1)
|
€
|
€
|
||
|
France
|
|
|
||
|
Italy
|
|
|
||
|
Germany
|
|
|
||
|
Brazil
|
|
|
||
|
Spain
|
|
|
||
|
United Kingdom
|
|
|
||
|
Poland
|
|
|
||
|
Slovakia
|
|
|
||
|
Serbia
|
|
|
||
|
Other countries
(2)
|
|
|
||
|
Total Non-current assets (other than financial instruments, deferred tax assets and post-
employment benefits assets)
|
|
|
||
|
31.
|
Explanatory notes to the Consolidated Statement of Cash Flows
|
|
Years ended December 31,
|
||||
|
2024
|
2023
|
|||
|
(€ million)
|
||||
|
Total Debt at January 1
|
€
|
€
|
||
|
Add: Derivative (assets)/liabilities and collateral at January 1
|
(
|
(
|
||
|
Add: Securities and financial receivables at January 1
|
(
|
(
|
||
|
Total Liabilities from financing activities at January 1
|
€
|
€
|
||
|
Cash flows
(1)
|
|
(
|
||
|
Foreign exchange effects
|
|
(
|
||
|
Fair value changes
|
|
|
||
|
Changes in scope of consolidation
|
|
|
||
|
Transfer to (assets)/liabilities held for sale
|
(
|
(
|
||
|
Other changes
|
|
(
|
||
|
Total Liabilities from financing activities at December 31
|
€
|
€
|
||
|
Less: Derivative (assets)/liabilities and collateral at December 31
|
(
|
(
|
||
|
Less: Securities and financial receivables at December 31
|
(
|
(
|
||
|
Total Debt at December 31
|
€
|
€
|
||
|
32.
|
Qualitative and quantitative information on financial risks
|
|
33.
|
Subsequent events
|
|
Payments due by period
|
||||||||||
|
(€ million)
|
Total
|
Less than 1
year
|
1-3 years
|
3-5 years
|
More than
5 years
|
|||||
|
Long-term debt
(1)
|
€
32,273
|
€
13,534
|
€
5,376
|
€
4,221
|
€
9,142
|
|||||
|
Interest on Long-term debt
(2)
|
2,679
|
465
|
722
|
545
|
947
|
|||||
|
Lease liabilities
(3)
|
2,852
|
866
|
643
|
358
|
985
|
|||||
|
Short-term leases and Low-value assets obligations
(4)
|
119
|
90
|
27
|
2
|
—
|
|||||
|
Unconditional minimum purchase obligations
(5)
|
19,871
|
3,371
|
8,507
|
5,559
|
2,434
|
|||||
|
Purchase obligations
(6)
|
10,250
|
6,419
|
3,312
|
472
|
47
|
|||||
|
Pension contribution requirements
(7)
|
81
|
81
|
—
|
—
|
—
|
|||||
|
Total
|
€
68,125
|
€
24,826
|
€
18,587
|
€
11,157
|
€
13,555
|
|||||
|
Country
|
Location
|
|
|
North America
|
||
|
U.S.
|
Warren, Michigan
|
|
|
U.S.
|
Sterling Heights, Michigan
|
|
|
U.S.
|
Belvidere, Illinois
|
|
|
U.S.
|
Toledo, Ohio (Toledo North)
|
|
|
U.S.
|
Detroit, Michigan (Detroit Assembly Complex - Jefferson)
|
|
|
U.S.
|
Detroit, Michigan (Detroit Assembly Complex - Mack)
|
|
|
U.S.
|
Toledo, Ohio (Toledo South)
|
|
|
Mexico
|
Toluca, Estado de México
|
|
|
Mexico
|
Saltillo, Coahuila (Saltillo Truck)
|
|
|
Mexico
|
Saltillo, Coahuila (Saltillo Van)
|
|
|
Canada
|
Windsor, Ontario
|
|
|
Canada
|
Brampton, Ontario
|
|
|
South America
|
||
|
Brazil
|
Betim
|
|
|
Brazil
|
Goiana
|
|
|
Brazil
|
Porto Real
|
|
|
Argentina
|
Buenos Aires
|
|
|
Argentina
|
Cordoba
|
|
|
Enlarged Europe
|
||
|
France
|
Hordain
|
|
|
France
|
Mulhouse
|
|
|
France
|
Poissy
|
|
|
France
|
Rennes
|
|
|
France
|
Sochaux
|
|
|
Germany
|
Eisenach
|
|
|
Germany
|
Russelsheim
|
|
|
Italy
|
Turin (Mirafiori)
|
|
|
Italy
|
Cassino
|
|
|
Italy
|
Pomigliano
|
|
|
Italy
|
Melfi
|
|
|
Italy
|
Val Di Sangro
|
|
|
Poland
|
Gliwice
|
|
|
Poland
|
Tychy
|
|
|
Slovakia
|
Trnava
|
|
|
Serbia
|
Kragujevac
|
|
|
Spain
|
Madrid
|
|
|
Spain
|
Vigo
|
|
|
Spain
|
Zaragoza
|
|
|
UK
|
Ellesmere Port
|
|
|
UK
|
Luton
|
|
Years Ended December 31,
|
||||
|
(€ million)
|
2024
|
2023
|
||
|
Audit fees
|
42.1
|
€
40.8
|
||
|
Audit-related fees
|
0.7
|
0.4
|
||
|
Tax fees
(1)
|
0.6
|
0.6
|
||
|
Total
|
€
43.4
|
€
41.8
|
||
|
Period
|
Total Number of Shares
Purchased
|
Average Price Paid per
Share (€)
(1)
|
Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs
|
Maximum Number of
Shares that May Yet Be
Purchased under the Plans
or Programs
|
||||
|
Jan 1 to Jan 31, 2024
|
—
|
—
|
—
|
181,608,866
|
||||
|
Feb 1 to Feb 28, 2024
|
3,474,314
|
24.33
|
3,474,314
|
178,134,552
|
||||
|
March 1 to March 31, 2024
|
11,132,699
|
25.72
|
11,132,699
|
167,001,853
|
||||
|
April 1 to April 30, 2024
|
26,487,768
|
23.75
|
26,487,768
|
297,364,019
|
||||
|
May 1 to May 31, 2024
|
9,620,527
|
20.55
|
9,620,527
|
287,743,492
|
||||
|
June 1 to June 30, 2024
|
41,405,101
|
19.38
|
41,405,101
|
246,338,391
|
||||
|
July 1 to July 31, 2024
|
—
|
—
|
—
|
246,338,391
|
||||
|
Aug 1 to Aug 31, 2024
|
21,250,616
|
14.54
|
21,250,616
|
225,087,775
|
||||
|
Sept 1 to Sept 30, 2024
|
43,440,446
|
13.79
|
43,440,446
|
181,647,329
|
||||
|
Oct 1 to Oct 31, 2024
|
7,350,270
|
12.49
|
7,350,270
|
174,297,059
|
||||
|
Nov 1 to Nov 30, 2024
|
—
|
—
|
—
|
174,297,059
|
||||
|
Dec 1 to Dec 31, 2024
|
—
|
—
|
—
|
174,297,059
|
||||
|
Total
|
164,161,741
|
18.27
|
164,161,741
|
174,297,059
|
|
Exhibit
Number
|
Description of Documents
|
|
1.1
|
|
|
1.2
|
|
|
2.1
|
|
|
Certain long-term debt instruments, none of which relates to indebtedness that exceeds 10% of the consolidated assets of
Stellantis N.V., have not been filed as exhibits to this Form 20-F. Stellantis N.V. agrees to furnish the Securities and
Exchange Commission, upon its request, a copy of any instrument defining the rights of holders of long-term debt of
Stellantis N.V. and its consolidated subsidiaries.
|
|
|
4.1
|
|
|
4.2
|
|
|
4.3
|
|
|
4.4
|
|
|
4.5
|
|
|
4.6
|
|
|
8.1
|
|
|
11.1
|
|
|
12.1
|
|
|
12.2
|
|
|
13.1
|
|
|
13.2
|
|
|
23.1
|
|
|
23.2
|
|
|
97.1
|
|
|
101.INS
|
XBRL Instance Document
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
Item
|
Section
|
Cross Reference
|
Page
|
|
Part I
|
|||
|
Item 1.
|
Identity of Directors, Senior Management and Advisers
|
Not applicable
|
|
|
Item 2.
|
Offer Statistics and Expected Timetable
|
Not applicable
|
|
|
Item 3.
|
Key Information
|
||
|
B. Capitalization and Indebtedness
|
Not applicable
|
||
|
C. Reasons for the Offer and Use of Proceeds
|
Not applicable
|
||
|
D. Risk Factors
|
|||
|
Item 4.
|
Information on the Company
|
||
|
A. History and Development of the Company
|
|||
|
B. Business Overview
|
|||
|
to the Consolidated Financial Statements
|
|||
|
C. Organization Structure
|
Consolidated Financial Statements
|
||
|
D. Property, Plant and Equipment
|
|||
|
Item 4A.
|
Unresolved Staff Comments
|
None
|
|
|
Item 5.
|
Operating and Financial Review
|
||
|
Consolidated Financial Statements
|
|||
|
A. Operating Results
|
|||
|
B. Liquidity and Capital Resources
|
|||
|
Note 22 (Debt)
to the Consolidated
Financial Statements
|
|||
|
the Consolidated Financial Statements
|
|||
|
C. Research and Development, Patents and Licenses, etc.
|
|||
|
D. Trend Information
|
|||
|
E. Critical Accounting Estimates
|
Consolidated Financial Statements
|
||
|
Item 6.
|
Directors, Senior Management and Employees
|
||
|
A. Directors and Senior Management
|
|||
|
Item
|
Section
|
Cross Reference
|
Page
|
|
B. Compensation
|
Remuneration Report
|
||
|
the Consolidated Financial Statements
|
|||
|
C. Board Practices
|
|||
|
D. Employees
|
|||
|
E. Share Ownership
|
|||
|
F. Disclosure of a Registrant's Actions to Recover Erroneously
Awarded Compensation
|
|||
|
Item 7.
|
Major Shareholders and Related Party Transactions
|
||
|
A. Major Shareholders
|
|||
|
B. Related Party Transactions
|
the Consolidated Financial Statements
|
||
|
C. Interests of Experts and Counsel
|
Not applicable
|
||
|
Item 8.
|
Financial Information
|
||
|
A. Consolidated Statements and Other Financial Information
|
|||
|
to the Consolidated Financial Statements
|
|||
|
B. Significant Changes
|
|||
|
Item 9.
|
The Offer and Listing
|
||
|
A. Offer and Listing Details
|
|||
|
B. Plan of Distribution
|
Not applicable
|
||
|
C. Markets
|
|||
|
D. Selling Shareholders
|
Not applicable
|
||
|
E. Dilution
|
Not applicable
|
||
|
F. Expenses of the Issue
|
Not applicable
|
||
|
Item 10.
|
Additional Information
|
||
|
A. Share Capital
|
Not applicable
|
||
|
B. Memorandum and Articles of Association
|
|||
|
C. Material Contracts
|
|||
|
D. Exchange Controls
|
|||
|
E. Taxation
|
|||
|
F. Dividends and Paying Agents
|
Not applicable
|
||
|
G. Statements of Experts
|
Not applicable
|
||
|
H. Documents on Display
|
|||
|
I. Subsidiary Information
|
Not applicable
|
||
|
J. Annual report to security holders
|
Not applicable
|
||
|
Item 11.
|
Quantitative and Qualitative Disclosures
|
Consolidated Financial Statements
|
|
|
Item
|
Section
|
Cross Reference
|
Page
|
|
Item 12.
|
Description of Securities Other than Equity Securities
|
||
|
A. Debt Securities
|
Not applicable
|
||
|
B. Warrants and Rights
|
Not applicable
|
||
|
C. Other Securities
|
Not applicable
|
||
|
D. American Depositary Shares
|
None
|
||
|
Part II
|
|||
|
Item 13.
|
Defaults, Dividend Arrearages and Delinquencies
|
None
|
|
|
Item 14.
|
Material Modifications to the Rights of Security Holders and
Use of Proceeds
|
None
|
|
|
Item 15.
|
Controls and Procedures
|
||
|
Item 16A.
|
Audit Committee Financial Expert
|
||
|
Item 16B.
|
Code of Ethics
|
||
|
Item 16C.
|
Principal Accountant Fees and Services
|
||
|
Item 16D.
|
Exemptions from the Listing Standards for Audit Committees
|
None
|
|
|
Item 16E.
|
Purchases of Equity Securities by the Issuer and Affiliated
Purchasers
|
Note 28 (Equity)
to the Consolidated
Financial Statements
|
|
|
Item 16F.
|
Change in the Registrant's Certifying Accountant
|
Not applicable
|
|
|
Item 16G.
|
Corporate Governance
|
||
|
Item 16H.
|
Mine Safety Disclosure
|
None
|
|
|
Item 16I.
|
Disclosure Regarding Foreign Jurisdictions that Prevent
Inspections
|
None
|
|
|
Item 16J.
|
Insider trading policies
|
||
|
Item 16K.
|
Cybersecurity
|
||
|
Part III
|
|||
|
Item 17.
|
Financial Statements
|
||
|
Item 18.
|
Financial Statements
|
||
|
Item 19.
|
Exhibits
|
||
|
STELLANTIS N.V.
|
|||
|
(Registrant)
|
|||
|
By:
|
/s/ Doug Ostermann
|
||
|
Name: Doug Ostermann
|
|||
|
Title: Chief Financial Officer
|
|||
|
Date:
|
February 27, 2025
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|